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                                                             ABSTRACT 
 
 
          Roberts syndrome (RBS) is a human developmental disorder characterized by 
craniofacial abnormalities, limb malformation and often severe mental retardation. RBS 
arises from mutations in the cohesin auxiliary factor ESCO2 that targets the SMC3 
subunit of the cohesin complex. Mutations in cohesin subunits and a subset of cohesin 
auxiliary factors gives rise to a related developmental malady termed Cornelia de Lange 
Syndrome (CdLS). They are collectively termed cohesinopathies since both disorders 
comprise overlapping phenotypes and the causative genes for both syndromes perform 
common activities. The underlying cause of CdLS is largely modeled as occurring 
through transcriptional deregulation. Whereas, the mechanism that underlies RBS, 
remains unknown. A popular model states that RBS arises due to mitotic failure that 
leads to elevated levels of apoptosis. My thesis is based on developing a new vertebrate 
model system for examining RBS-like skeletal defects in order to better understand the 
mechanisms underlying the disease. Using the zebrafish regenerating fin model, I 
discovered a transcriptional role of esco2 during fin regeneration. First, my results show 
that Esco2 contributes to skeletal growth and patterning independent of elevated levels of 
apoptosis – negating a model for mitotic failure. Second, I provide the first 
characterization of Esco2-dependent gene expression of a skeletal gene, cx43, which 
encodes the gap junction connexin subunit required for cell-cell communication and 
skeletal development in all vertebrates. Mutations in human CX43 gives rise to a skeletal 
disorder, Oculodentodigital dysplasia (ODDD). My results conceptually link ODDD to 
cohesinopathies and provide evidence that ESCO2 may play a transcriptional role critical 
for human development. I next addressed the mechanism through which Esco2 regulates 
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cx43 expression, focusing on the Esco2 target Smc3. My results show that the Smc3 
knockdown perturbs bone and tissue growth that recapitulates RBS-type phenotypes in 
the regenerating fin model. Importantly, Smc3 regulates cx43 expression, similar to that 
of Esco2. Moreover, Chromatin Immunoprecipitation (ChIP) assays revealed that Smc3 
binds to a discrete region of the cx43 promoter, suggesting that Esco2 exerts 
transcriptional regulation of cx43 through modification of Smc3 bound to the cx43 
promoter. These findings unify RBS and CdLS as transcription-based mechanisms. 
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                                                             CHAPTER 1 
 
                                                             
 
 
 
                                                             Introduction 
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1.1 The Cohesin ring complex and its auxiliary factors  
          The fundamental component of many cellular processes is the tethering together of 
two DNA segments, either in cis (intramolecular) or trans (intermolecular) conformations 
(Zakari et al., 2015; Skibbens, 2016). For instance, DNA segment trans-tethers between 
two separate DNA molecules, such as sister chromatids, identify the products of 
chromosome replication as sisters from S phase until anaphase onset. In addition to 
ensuring high fidelity chromosome segregation, trans tethers ensure proximity of 
template DNA required for error-free DNA repair events. On the other hand, cis-DNA 
tethering occur at the base of a single DNA molecule forming looped structures that 
brings into registration regulatory elements such as enhancers, promoters, insulators, 
terminators, etc. that deploy developmental transcription programs largely thought to 
occur during the G1 stage of the cell cycle. DNA segment cis-tethers also promote 
longitudinal compaction of DNA molecules that is required for regional changes in 
chromatin structure during G1 and genome-wide chromosome condensation during 
mitosis. Interestingly, a single complex that participates in various essential cellular 
activities via both cis and trans-DNA-tethering conformations is the multi-subunit 
cohesin complex and along with its auxiliary factors (Figure 1.1). 
          Cell division is a fundamental process by which cells replicate and generate 
identical daughter cells. The process of cells duplicating themselves starts with the S 
phase in which each parent cell replicates its chromosomes and ends with Mitosis in 
which sister chromatids segregate into newly formed daughter cells. For proper 
functioning of the cell cycle, it is essential for the sister chromatids to be tethered 
together until the chromosomes are ready to separate. This process is collectively termed 
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as cohesion and is maintained by the multi-protein cohesin complex along with numerous 
auxiliary factors (Skibbens, 2009).  
          Cohesin complexes are evolutionarily conserved from yeast to humans and are 
composed of five core subunits, SMC1A, SMC3, RAD21/MCD1/SCC1, 
SA1,2/STAG1,2/Irr1/Scc3 and PDS5 (Figure 1.1). SMC1A and SMC3 are elongated 
ATPase proteins that together form a ring, which is stabilized by RAD21/ MCD1/SCC1. 
RAD21 in turn recruits the remaining components (PDS5 and either SA1 or SA2) 
(Jeppssen 2014; Marston 2014; Skibbens 2016). The exact mechanism through which 
DNA becomes entrapped within this flattened cohesin ring remains enigmatic, but could 
involve one, or more than one, cohesin rings. Cohesins are incapable of binding DNA 
spontaneously. Instead, a series of auxiliary factors are required for cohesins to bind 
DNA prior to functioning in chromosome segregation, chromatin condensation, DNA 
repair, and transcriptional regulation. The NIPBL/SCC2 and MAU-2/SCC4 deposition 
heterocomplex is required to load cohesins onto DNA segments (Ciosk 2000; Seitan 
2006; Rollins 1999; Rollins 2004). The rules governing cohesin deposition are poorly 
understood. Once chromatin-bound, however, cohesins must become activated 
(promoting cohesin oligomerization and/or stabilizing DNA entrapment). The N-
acetyltransferase family of proteins, ESCO2/EFO2/ESCO1/EFO1/Ctf7/Eco1 supplies this 
role. The ESCO families of protein are highly conserved acetyltransferases that activates 
SMC3 through acetylation, which is required for all subsequent cohesin-dependent 
activities (Skibbens et al., 1999; Toth et al., 1999; Ivanov et al., 2002; Bellows et al., 
2003; Hou and Zou, 2005; Rolef Ben-Shahar et al., 2008; Zhang et al., 2008). Cohesins 
must also be turned off, either to allow for sister chromatid separation at anaphase onset 
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or to respond to transcriptional responses to external cues through tether 
disassembly/reassembly. Cohesin inactivation at anaphase onset is irreversible and occurs 
through RAD21 degradation, although a non-proteolytic release mechanism can reduce 
cohesin binding during prophase (Funabiki 1996; Ciosk 1998; Uhlmann and Nasmyth 
1999; Shintomi and Hirano, 2010). On the other hand, cohesin inactivation during G1 
likely occurs through disassociation of cohesin dimers. In both cases, HDAC8/Hos1 
deacetylase helps reset the acetylation state of SMC3 (Xiong et al., 2010; Borges et al., 
2010; Beckouet et al., 2010; Deardorff et al., 2012a). 
 
1.2 Cohesion-mediated trans and cis-DNA tethering functions 
       Historically, cohesins were identified for their role in the trans-DNA tethering 
mechanisms such as sister chromatid cohesion and segregation. But recently, numerous 
findings brought to light the cis-DNA tethering functions of cohesins (Figure 1.1). 
Cohesins function in stabilizing DNA loops by promoting or precluding registration of 
enhancers and promoters in close proximity. Other cis-DNA tethering roles of cohesins 
include condensation and ribosome biogenesis. Genome-wide studies report direct 
association of cohesin subunits and cohesin auxiliary factors with developmental genes. 
Thus one of the possible mechanisms that underlie the transcriptional regulation of 
cohesin is via long distance DNA looping. Additional studies from various groups show 
cohesin facilitates long distance DNA looping (Hadjur et al., 2009; Mishiro et al., 2009; 
Nativio et al., 2009; Hou et al., 2010). Interestingly, in mouse embryonic stem cells 
cohesin binding initiates enhancer-promoter interaction via DNA loops in 
transcriptionally active genes (Figure 1.2; Kagey et al., 2010). They provide in vivo 
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evidence of physical interaction and co-occupancy of the cohesin, mediator and NIBPL at 
the enhancer and core promoter regions of active genes. This group of researchers 
suggested that co-activator- bound mediator complex undergoes conformational changes 
and binds to the cohesin and NIBPL. This leads to the enhancer- promoter DNA loop 
formation and eventually overall gene activation. This study suggests the possibility that 
such long distance DNA looping may exist that affects the gene expression and thus 
results in various developmental disorders.  
 
1.3 Cohesion pathway mutations leads to cohesinopathies 
           Skeletal defects, especially long bone growth and morphogenesis, are components 
of a number of multi-spectrum developmental abnormalities. These include Roberts 
syndrome (RBS), Cornelia de Lange Syndrome (CdLS) (Krantz et al., 2004; Tonkin et 
al., 2004; Schule et al., 2005; Vega et al., 2005; Musio et al., 2006; Deardorff et al., 2007; 
Gordillo et al., 2008; Deardorff et al., 2012a; Deardorff et al., 2012b). Genetic mapping 
studies revealed that mutations in the genes of the cohesion pathway give rise to these 
diseases and thus grouped them into a common disease category collectively termed 
cohesinopathies.  
          RBS is characterized by pre- and postnatal growth retardation affecting the limbs 
and craniofacial bone structures. Dr. John B. Roberts reported the earliest case back in 
1919 and thus named in his honor. All four limbs are affected in RBS patients such that 
children are born with shortened arm and leg bones. Facial abnormalities are significant 
symptoms of RBS, which includes cleft lip, cleft palate, small chin and corneal clouding 
(Berg and Francke, 1993; Vega et al., 2005). Infants born with severe forms of RBS are 
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stillborn and the mortality rate is quite high (Schule et al., 2005). To date, roughly 150 
cases of RBS have been reported.     
        CdLS is a similar disorder that exhibits significantly overlapping and severe 
phenotypes as RBS. Both RBS and CdLS patients, in addition to severe long-bone 
growth defects and missing digits, exhibit craniofacial abnormalities, cleft palate, 
syndactyly, organ defects and severe mental retardation (Van den Berg and Francke, 
1993; Schule et al., 2005; Vega et al., 2005; Liu and Krantz, 2009; Mannini et al., 2010). 
Figure 1.3 depicts the phenotypes observed in RBS and CdLS patients. 
 
1.4 Genetic basis of RBS and CdLS  
         RBS is an autosomal recessive disorder that arises from mutations in the 
acetyltransferase ESCO2 (Vega et al., 2005; Schule et al., 2005; Gordillo et al., 2008). In 
2005, the gene responsible for RBS was identified and characterized as ESCO2 
(Establishment of Cohesion 1 homolog 2). The 30.3kb coding sequence is divided into 11 
exons, with the start and stop codon on exon 2 and exon 11 respectively (Figure 1.4). 
ESCO2 has a predicted size of 68.3 kDa and is evolutionarily conserved among 
vertebrate species (Vega et al., 2005). The C-terminal of ESCO2 is similar to Eco1/Ctf7 
of yeast (Skibbens et al., 1999; Ivanov et al., 2002). ESCO2 C-terminal is evolutionary 
conserved and belongs to the Eco1p family of proteins. These proteins have N-
acetytransferase activity and play an important role in the process of sister chromatid 
cohesion during the S phase of cell cycle. Table 1.1 lists the different names of the 
protein in various model organisms (Horsfield et al., 2012).  
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        CdLS on the other hand is an autosomal dominant disorder that arises from 
heterozygous or X-linked mutations in the cohesion subunits SMC1A, SMC3, RAD21, as 
well as in the auxiliary factors NIPBL and HDAC8 (Krantz et al., 2004; Tonkin et al., 
2004; Musio et al., 2006; Deardorff et al., 2007; Deardorff et al., 2012a; Deardorff et al., 
2012b). CdLS occurs approximately 1 in 10,000 live births (Opitz, 1985; Krantz et al., 
2004), and around 65% of the reported cases arise from mutations in the NIPBL gene 
(Krantz et al., 2004; Tonkin et al., 2004; Zakari et al., 2015).  
 
1.5 Mechanisms posited to produce RBS and CdLS 
          Intriguingly, the mechanisms through which mutations contribute to 
cohesinopathies are thought to vary widely. Cells isolated from RBS patients exhibit 
chromosomal segregation defects, premature centromere separation (PCS), 
heterochromatin repulsion (HR), lagging chromosomes, aneuploidy, elevated levels of 
apoptosis and reduced cell proliferation which is consistent with the role of Esco2 (Figure 
1.5) (Schule et al., 2005; Vega et al., 2005; Gordillo et al., 2008; Mehta et al., 2013 and 
Horsfield et al., 2012). In contrast, cells from CdLS patients do not exhibit PCS/HR 
cellular morphology or mitotic defects (Krantz et al., 2004). Because of the distinct 
cellular phenotypes, defects in trans-DNA tethering events were initially believed to be 
the underlying cause of RBS. Whereas due to the lack of overt defects in trans-DNA 
tethering and early studies that linked Drosophila Nipped B (NIPBL homolog) to 
transcription regulation, the underlying cause of CdLS is largely modeled as occurring 
through defects in cis DNA-tethering (Figure 1.6). Analyses of various model systems 
reveal that multiple mechanisms within each syndrome may be at work (discussed in 
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review article, Banerji et al., 2017, in revision). Below, I discuss in detail the suggested 
mechanisms underlying both RBS and CdLS. 
 
(1) Apoptosis is activated in both RBS and CdLS 
          Currently the mechanism of RBS pathogenesis is unclear. To date, ESCO2 
mutations are the only etiologic genetic agent known to produce RBS. The popular model 
of RBS suggests reduced progenitor cell proliferation and increased mitotic failure 
accompanied by apoptosis as the underlying mechanism (Monnich et al., 2011). Studies 
using ESCO2 knockout mice report both cohesion defects and roughly two-fold increase 
in apoptotic cells, similar to RBS patient cells (Whelan et al., 2012; Gordillo et al., 2008, 
van der Lelij et al., 2009 ). Similar findings are observed in studies using both zebrafish 
and medaka embryos, establishing teleosts as a powerful model from which to study the 
molecular pathologies that underlie RBS (Monnich et al., 2011; Morita et al., 2012). In 
zebrafish, esco2 morpholinos (MO) cause lethality by 72 hours post ferlilization (hpf), 
but reducing the dosage permits bone and cartilage development (Monnich et al., 2011). 
These esco2 morphants exhibited craniofacial cartilage defects, under-developed jaws 
and shorter pectoral fins, characteristic of RBS phenotypes. They found RBS to arise 
through reduced progenitor cell proliferation and increased incidences of both mitotic 
failure and apoptosis.  
          Similar findings are observed in esco2 mutants (Morita et al., 2012; Percival et al., 
2015). By using Targeted Induced Local Lesions in Genomics (TILLING) approach one 
group found a missense mutation (R80S) that was responsible for the RBS-like 
phenotypes in the medaka (Morita et al., 2012). Interestingly, the phenotypes of the 
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homozygous esco2R80S mutants are very similar to the esco2 morphants. esco2R80S 
mutants have a variety of clinical phenotypes arising from a single mutation. Recently, a 
study using zebrafish esco2hi2865 mutant (with a retroviral insertion in intron 1 of a gene 
which has homology with ESCO2 gene) reported the apoptotic response to be p53-
dependent, consistent with mitotic failure. However, a subset of mutant cells exhibits 
normal mitoses, suggesting the potential for multiple mechanisms underlying RBS 
phenotypes (Percival et al., 2015). 
       Apoptosis may be an under-appreciated phenotype of CdLS, since there are reports 
that CdLS cells do not exhibit mitotic defects and apoptosis (Krantz et al., 2004). It is 
important to point out that there are reports however, of mitotic defects occurring in 
CdLS patient cell lines (Kaur et al., 2005). Moreover, there are reports of increased levels 
of apoptosis in zebrafish morphants for the cohesin subunits (smc3, smc1a, rad21a,) and 
the cohesin loading factor (nipblb) that give rise to CdLS in humans (Ghiselli, 2006; 
Fazio et al., 2016, Schuster et al., 2015; Pistocchi et al., 2013). Knockdown of cohesin 
subunits also exhibit p53-dependent apoptosis, consistent with cell death due to mitotic 
failure (Ghiselli, 2006; Schuster et al., 2015).  
 
(2) Transcriptional deregulation underlie both RBS and CdLS 
         There is strong evidence that suggests that CdLS arises from misregulation of 
developmental genes (Bose et al., 2012; Dorsett, 2010; Dorsett and Merkenschlager, 
2013). It is now well established that cohesins regulate transcriptional processes 
involving transcription termination, enhancer-promoter registration, CTCF-insulator 
recruitment and RNAPII transitioning (Dorsett and Krantz, 2009; Cucco and Musio, 
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2016; Dorsett and Merkenschlager, 2013). But the extent to which cohesin and its 
auxiliary factors function through a single common mechanism or through multiple 
mechanisms remains an important developmental issue.  
          One mechanism includes long- distance DNA looping which plays an important 
part in cohesin-mediated gene regulation (Ball et al., 2014; Kagey et al., 2010). Cohesin 
recruitment to these loops involves the CCCTC-binding factor (CTCF) insulator. CTCF 
binds to specific DNA motifs and in turn recruits cohesins to these specific loci (Wendt 
and Peters, 2009; Hadjur et al., 2009; Hou et al., 2010; Kagey et al., 2010; Ball et al., 
2014; Parelho et al., 2008; Rubio et al., 2008). In fact, studies from numerous model 
systems suggest that CTCF both precludes enhancer-promoter interactions through DNA 
looping and recruits cohesins for loop stabilization (Wendt and Peters, 2009; Degner et 
al., 2011; Nativio et al., 2011; Majumder and Boss, 2011; Guo et al., 2012). In 
mammalian cells, there is more than 50% overlap between cohesin and CTCF binding 
sites (Wendt et al., 2008). In zebrafish, cohesin both positively (i.e. CTCF independent) 
and negatively (i.e. CTCF-dependent) regulates transcription factor runx1 expression 
(Rhodes et al., 2010). Intriguingly, Drosophila CTCF and cohesin colocalization appears 
reduced (Misulovin et al., 2008; Pauli et al., 2008; Van Bortle et al., 2014). In 
combination these findings suggest that while defects in CTCF recruitment of cohesin 
may contribute to cohesinopathies, additional mechanisms must be at play (Mourad and 
Cuvier, 2016).  
        In addition to CTCF, the transcription co-activator Mediator is implicated in 
cohesin-dependent transcription. Mediator is a large complex that recruits RNAPII to the 
promoter (Kagey et al., 2010; Conaway et al., 2005; Kornberg, 2005; Taatjes, 2010; 
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Malik and Roeder, 2005; Roeder, 1998). Mutations in the Drosophila NIPBL ortholog, 
Nipped-B, are linked to long-distance enhancer-mediated transcriptional changes that 
occur during development (Rollins et al., 1999; Dorsett, 2016). Evidence from embryonic 
stem cells suggests that Mediator participates in this cohesin-dependent DNA looping 
(Kagey et al., 2010), consistent with similar findings regarding transcription factor hoxd 
in zebrafish nipbla/b morphants (Muto et al., 2014). Changes in nuclear architecture in 
both nipbla/b and med12 single morphants, suggesting that expression of these genes is 
indeed mediated through chromatin looping (Muto et al., 2014). 
         New studies provide a growing body of evidence that RBS models, similar to 
CdLS, exhibit significant changes in gene expression (Banerji et al., 2016; Choi et al., 
2010; Leem et al., 2011; 288 Monnich et al., 2011; Xu et al., 2013; Xu et al., 2016; 
Rahman et al., 2015). Support for a transcriptional role of ESCO2 comes from studies 
using human cell lines that ESCO2 represses Notch transcription to promote neuronal 
differentiation (Leem et al., 2011). Interestingly, the study using esco2R80S medaka 
mutants show evidence of Esco2 functioning during embryogenesis by upregulating 
certain genes in the Notch pathway (Morita et al., 2012). Additionally, there is evidence 
that ESCO factors act as transcription repressors by recruiting chromatin modifiers (Choi 
et al., 2010; Kim et al., 2008). Additional evidence comes from the comparison of gene 
expression profiles from cohesin subunit, rad21 null mutants (rad21nz171) and esco2 
morphants that show a number of overlapping genes with altered expression profiles 
(Rhodes et al., 2010; Monnich et al., 2011). Intriguingly, this common gene pool 
exhibited opposing directions in gene expression: genes upregulated in the rad21nz171 
mutant were downregulated in esco2 morphant embryos, and vice versa.  An explanation 
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for such opposing transcriptional effects is likely due to differences in the loss of 
structural components (cohesin) verses enzymatic activities (Esco2). For instance, 
cohesins may remain chromatin bound and/or CTCF associated in esco2 morphants. 
Alternatively, opposing transcriptional effects between rad21nz171 mutants and esco2 
morphants may reflect direct verses indirect roles in transcription.  
        Based on the findings from various model systems, it is certain that the etiologies of 
RBS and CdLS (or in general all cohesinopathies) are not straightforward, but rather 
quite complex. Reports of transcriptional deregulation and apoptosis in both syndromes 
suggest that multiple mechanisms are at play. This unifying model may appear to be 
challenged by disparate findings regarding NIPBL, cohesin and CTCF residency on 
chromatin (Misulovin et al., 2008; Kagey et al., 2010; Muto et al., 2011; Zuin et al., 
2014; Minamino et al., 2015; Rahman et al., 2015). It is tempting to speculate that 
disparities in cohesin recruitment to DNA, as well as identified binding partners, reflect 
unique cohesin complexes that occur in different tissues and mediate different functions 
(i.e. transcriptional repression vs. activation). Further efforts in testing a unifying 
transcriptional basis for all cohesinopathies include identifying the mechanisms through 
which cohesins are deposited on specific loci, elucidating how chromatin-associated 
cohesins mediate trans versus cis conformations, and assessing how those complexes 
impact gene expression profiles.  
 
1.6 Using the zebrafish caudal fin to distinguish between different RBS models 
        The zebrafish regenerating fin is a powerful model system, which could provide 
valuable evidence to distinguish between different RBS models. For instance, the  
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zebrafish CNS, heart, gut, and cephalic structures appear exquisitely sensitive to cohesins 
and Nipbl levels (Muto et al., 2011; Pistocchi et al., 2013; Muto et al., 2014; Fazio et al 
2016). Similar to humans, the zebrafish genome harbors orthologues of most cohesion 
genes (nipbla and nipblb, esco1 and esco2, smc1a and smc1al, smc3, rad21a and rad21b, 
stag1a/b and stag2a/b and stag3; pds5a and pds5b). Gene function may be examined 
through generation of mutant alleles using genome editing (Hwang et al., 2013; Seruggia 
and Montoliu, 2014) or by the use of gene targeting MOs (Nasevicius and Ekker, 2000). 
Our lab uses the zebrafish caudal fin to study skeletal morphogenesis. Because of its 
simple structure, easy accessibility, rapid regeneration following amputation, limited cell 
type composition, and the ability to knock down gene expression through gene-specific 
MOs, this is emerging as an excellent model system to elucidate tissue and bone growth 
pathways (Iovine et al., 2005). Investigating how Esco2 levels are affected in the 
zebrafish skeleton will provide new insights into the cohesinopathy field. 
 
1.7 The fascinating process of zebrafish epimorphic fin regeneration 
        The caudal fin is composed of 16 to 18 segmented bony fin rays or lepidotrichia 
with new growth occurring by the distal addition of bony segments and associated fin ray 
joints (Figure 1.7) (Haas, 1962; Goss et al., 1957). Each bony fin ray is made up of two 
concave hemirays that surrounds mesenchymal cells (Santamaria et al., 1992). These 
hemirays are lined by osteoblasts that secrete the bone matrix and primarily enclose the 
mesenchymal compartment, which consists of mesenchymal cells, blood vessels, nerves, 
melanocytes and fibroblasts. A layer of epithelial cells covers the entire fin and ontogenic 
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fin growth occurs by successive addition of bony segments to the distal tip of the fin 
(Haas, 1962).  
          Zebrafish are capable of impressive epimorphic regeneration in a variety of tissues 
such as caudal fin, skin, retina and heart. The process can be defined as a post-traumatic 
morphogenetic event where a specialized compartment of highly proliferating cells 
(blastemal) are formed at the wound site by the aggregation of mesenchymal cells 
(Akimenko et al., 2003; Schebesta et al., 2006). Regeneration of the adult caudal fin is a 
fascinating process by which the lost tissue is restored in approximately 2 weeks 
following amputation (Figure 1.8). The 3 phases of the regeneration process consists of 
wound healing, blastema formation and regenerative outgrowth (Nechiporuk and 
Keating, 2002). The process of regeneration starts 12-24 hours post amputation (hpa) by 
wound healing by sealing the wound with migrating epithelial cells. After 12 hours there 
is thickening of the epidermis and the disorganized cells migrate towards the amputation 
plane to the blastema. It is important that a multilayered epidermis is formed during 
blastema formation and proliferation (Lee et al, 2009). The blastema consists of highly 
proliferative and undifferentiated cells that express different molecular markers such as 
msxb and msxe that label undifferentiated cells (Barker and Beck, 2009; Han et al., 2003). 
During the final regenerative outgrowth phase after 48-72 hpa, the blastema 
compartmentalizes into proximal and distal zones. After 72 hpa and later, outgrowth 
process takes place where cells migrate in both proximal and lateral directions 
(Nechiporuk and Keating, 2002). 
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1.8 CX43 is important for growth and development of vertebrate skeleton  
         Our lab uses the zebrafish regenerating fin as a tool to understand the molecular 
mechanisms regulating skeletal morphogenesis in vertebrates. Previously, our lab has 
established that homozygous mutations in a gap junction gene, connexin43 (cx43) cause 
the short fin (sof b123) phenotype. The sof b123 mutant is characterized by short bony fin 
ray segments, short fins, and reduced cell proliferation (Figure 1.9; Iovine et al., 2005 and 
Hoptak-Solga et al., 2008). Importantly, MO-mediated Cx43 knockdown in wild type 
regenerating fins also result in reduction in fin length, segment length and cell 
proliferation, recapitulating the phenotypes observed in sof b123 mutants (Hoptak-Solga et 
al., 2008).  
         Gap junctions are intracellular channels that are formed by the docking of two 
connexons of neighboring cells and freely permit direct exchange of small ions, second 
messengers and low molecular weight metabolites (<1000Da) (Figure 1.10). The 
connexons or hemichannels are made up of six four-pass transmembrane spanning 
proteins called connexins. Gap junctions play a vital role in developmental processes, 
tissue function, homeostasis maintenance, morphogenesis, cell differentiation, and 
growth control in multicellular organisms and during the process of skeletogenesis 
(Oyamada et al., 2005). In order to understand the role of Cx43 during skeletal 
development I utilize a zebrafish short fin mutant (sof b123).  
          Cx43 exhibits conserved functions in the vertebrate skeleton. Mutations in CX43 
cause skeletal defects in human, mouse, chick and zebrafish. For example, pleiotropic 
developmental disorder, Occulodentodigital dysplasia (ODDD, Paznekas et al, 2003, 
Figure 1.11) is associated with missense mutations in human CX43 gene. ODDD patients 
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exhibit skeletal and craniofacial abnormalities along with additional pleiotropic 
phenotypes such as eye and dental deformities. Also, a dominant mouse mutation in 
CX43 exhibits various skeletal and pleiotropic phenotypes similar to human ODDD 
(Flenniken et al., 2005). Additional studies show that targeted gene knockdown of CX43 
in adult chicks and in chick embryos results in facial abnormalities (Makarenkova and 
Patel, 1999) and limb malformation (McGonnell et al., 2001). Thus, the regenerating fin 
provides clinically relevant insights into highly conserved pathways critical for human 
skeletal development.  
          
1.9 Hypothesis and Research objective 
         RBS and CdLS are pleiotropic developmental disorders exhibiting severe growth 
retardation resulting in limbs and craniofacial abnormalities. They are collectively termed 
cohesinopathies since both disorders comprise overlapping phenotypes and the causative 
genes for both syndromes perform common activities. It is therefore surprising that CdLS 
and RBS are considered separate syndromes. A consensus regarding underlying 
molecular mechanisms obtained from various model systems remains elusive. Due to 
distinct cellular morphology exhibited by RBS and CdLS patient cells, at present the 
molecular mechanisms through which cells and developing organisms respond to 
cohesion still remain unclear (Mehta et al., 2013; Horsfield et al., 2012; Dorsett and 
Merkenschlager, 2013). But certainly, the etiology of these disorders is much more 
complex, and does not fall into the categories typically defined by the different syndrome 
names. Analyses of various model systems reveal that multiple mechanisms within each 
syndrome may be at work. It is now well established that cohesins play a direct role in 
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gene expression and the developmental defects in CdLS patients arise due to 
transcriptional deregulation. But the role of apoptosis in CdLS cannot be completely 
ruled out. For instance, there are reports of cohesion defects and elevated levels of 
apoptosis in CdLS patient cells and zebrafish morphants (Kaur et al., 2005; Ghiselli et al., 
2006; Fazio et al., 2016; Schuster et al., 2015). Currently, the role of apoptosis in CdLS is 
either underappreciated or not tested. On the other hand, mitotic failure and elevated 
levels of apoptosis is currently the popular model underlying RBS. Similar to cohesins, 
role of Esco2 has been reported in various cis-DNA tethering processes such as ribosome 
maturation and assembly, DNA repair and transcriptional regulation (Skibbens et al., 
1999; Skibbens et al., 2010; Gard et al., 2009; Bose et al., 2012; Terret et al., 2009; Unal 
et al., 2004; Zakari et al., 2015; Leem et al., 2011). The growing bodies of evidence 
suggest a transcriptional mechanism underlying RBS, similar to CdLS. Considering the 
complexity in the mechanisms underlying these disorders, it is important to investigate 
the role of apoptosis and transcriptional deregulation underlying both diseases.  
            My research objective is to understand if CdLS and RBS occur as a result from a 
similar mechanism. Particularly I am interested to test the transcriptional mechanism 
underlying RBS using the zebrafish regenerating fin. Prior work on the regenerating fin 
revealed that Cx43 is required for both cell proliferation and joint formation during fin 
regeneration (Iovine et al., 2005). Since human CX43 mutations cause a pleiotropic 
skeletal disorder Oculodentodigital dysplasia (ODDD) that overlap with those of both 
RBS and CdLS (Paznekas et al., 2003), I posit that ODDD is linked to cohesinopathies 
and that transcriptional deregulation of developmental genes such as CX43 may 
contribute to RBS phenotypes. My findings (discussed in the next chapters) suggest that 
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Esco2 and the cohesin subunit Smc3 function together to regulate cx43 expression during 
skeletal development. My work sheds light on a unified underlying mechanism of RBS 
and CdLS and in general all cohesinopathies. 
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1.10 Figures and Tables 
  
                
                       
 
 
Figure 1.1: DNA tethering mechanisms of cohesins and auxiliary factors. 
Schematic representation of the cohesin ring structure (composed of the 5 subunits; 
SMC1A, SMC3, RAD21, SA1,2 and PDS5)  and auxiliary factors, NIPBL (loader), 
ESCO2 (acetyltransferase) and HDAC8 (deacetylase). Cohesins and auxiliary factors 
regulate both cis and trans-DNA tethering events. Cis-DNA tethering processes include 
DNA looping mechanisms during transcription, condensation and ribosome biogenesis. 
Trans-DNA tethering processes include sister chromatid segregation during S phase of 
cell cycle and DNA repair events  
 
Source: Review article, Banerji et al., 2017 (in press, Developmental Dynamics) 
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Figure 1.2: Transcription-based DNA looping model. A model depicting the physical 
association of the mediator and cohesin complex, functionally connecting enhancers and 
core promoter of actively transcribing genes in murine embryonic stem cells. The 
formation of DNA loops between enhancer-bound transcription factors and the 
transcription apparatus at the core promoter resulting in gene activation. Nipbl, the 
cohesin-loader is associates with mediator-cohesin complexes, providing a mean to load 
cohesin at promoters (Kagey et al., 2010). 
Source: Surprise in genome structure linked to developmental diseases, Image: Tom 
DiCesare/Whitehead Institute (2010) 
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Figure 1.3: Multifaceted developmental disorders: RBS and CdLS. Characteristic 
features of RBS patients shown in left panel. Patients are characterized by skeletal 
deformities in limbs, missing digits, small head, cleft lip and palate. RBS limb reduction 
is mesomelic and symmetric in which the arms are more severely affected than the legs. 
Characteristic features of CdLS patients are shown in right panel. Patients are 
characterized by craniofacial abnormalities, organ defects and limb deformities. 
Variability of upper limb abnormalities and with missing and fused digits are commonly 
seen in CdLS patients. 
 
Source: Photographs of RBS patients (left, Vega et al., 2005) and CdLS patients (right, 
Krantz et al., 2004) 
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Figure 1.4: ESCO2 gene structure with location of identified mutations. Eight 
mutations identified in 15 families with RBS reported by Vega et al., 2005 (shown at the 
top). Seven mutations found in 5 families with RBS reported by Schule et al., 2005 
(shown at the bottom). White boxes -UTR, gray boxes - coding regions of exons 2–11. 
Location of the functional domains—the C2H2 zinc finger-like domain (diagonal stripes) 
and the acetyltransferase domain (horizontal stripes) are shown. 
 
Source: Schule et al., 2005. 
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Figure 1.5: Cellular morphology of RBS patient cells. The RBS patient cells exhibit 
characteristic railroad-track morphology (indicated with arrows), which is indicative of 
premature centromere separation (PCS) and heterochromatin repulsion. The arrowhead 
indicates the Y chromosome splitting in the heterochromatin region. Normal 
chromosomes are shown with open arrows. 
 
Source: Vega et al., 2005  
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Figure 1.6: Suggested models of cohesinopathies. Currently the suggested models of 
CdLS and RBS are distinct. CdLS arises due to cis-DNA tethering defects resulting in 
transcriptional deregulation. In contrast, RBS arises due to defects in trans-DNA 
tethering resulting in mitotic defects and elevated levels of apoptosis. 
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Figure 1.7: The zebrafish regenerating caudal fin is a model system for skeletal 
morphogenesis. (Top) A caudal fin is stained with calcein that detects bone matrix, 
revealing 16-17 bony fin rays comprised of bony segments separated by joints. (Bottom 
left) Representative image of a transverse section through a single fin ray is shown. 
White arrows indicate hemirays that are visible as crescents of bone surrounding 
mesenchymal tissue (m). The bony rays are surrounded by the epithelium (e) and basal 
layer of epithelium is the region with purple stain. (Bottom right) Schematic of a 
longitudinal section of the fin showing the different compartments as follows: Blastema 
(b), mesenchyma (m), epidermis (e), skeletal precursor cells (spc) and lepidotrichia (lep). 
The amputation plane is indicated by a black dotted line. 
 
Source: Iovine, 2007 (Top and bottom left panels); Govindan et al., 2016. 
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Figure 1.8: Stages of Fin regeneration. The three stages of epimorphic regeneration 
consist of (1) wound healing, (2) blastema formation and (3) the regenerative outgrowth 
phase. During wound healing, epithelial cells migrate distally to cover the wound by 
forming an apical epithelial cap. The blastema is a specialized compartment of the 
regenerating fin, consisting of highly proliferative cells. Cells in the blastema are divided 
into two subsets: distal most blastema cells and cells that is highly proliferative. During 
the final regenerative outgrowth phase, the gradient of msxb expression and proliferation 
is maintained, controlling the direction of outgrowth. Cells in the proliferative zone (pz) 
move in the proximal direction to differentiate. A zone of negative proliferation in the 
distal most blastema (dmb) maintains the directionality of the outgrowth by inhibiting 
proliferation.  
 
Source: Nechiporuk and Keating, 2002. 
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Figure 1.9: Fin length mutant (sof b123) exhibits defects in skeletal morphogenesis. 
(Top) Regenerate length (red arrows) and segment length indicated in wild-type 
zebrafish. (Bottom) sof b123 mutant zebrafish exhibits shorter regenerate length (green 
arrows) and shorter segment length (Iovine et al., 2005). 
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Figure 1.10: Gap junction channels function in direct cell-to-cell communications. 
Schematic representation of a single gap juction channel (connexin) containing four 
transmembrane-spanning domains, with both the amino and carboxy ends located in the 
cytoplasm. Six connexins comprise a connexon, or hemichannel. Two such connexons, 
from two neighbouring cells, dock together at the plasma membrane to make a functional 
gap junction channel. IL, intracellular loop; EL, extracellular loop. 
 
Source: Ton and Iovine, 2013 
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Figure 1.11: Cx43 is clinically relevant in vertebrates. (Left) Skeletal defects in the 
mouse model of Oculodentodigital Dysplasia (ODDD) are shown. (Right) ODDD 
phenotypes in humans are shown. These include craniofacial abnormalities, missing 
digits and problems in eye and teeth. 
 
Source: (Left) Flenniken et al., 2005; (Right) Musa et al., 2009 
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Table 1.1: Nomenclature and function of cohesin subunits and its auxiliary factors 
in various model systems.  
 
Source: Horsfield et al., 2012 
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2.1 Abstract 
Roberts syndrome (RBS) is a rare genetic disorder characterized by craniofacial 
abnormalities, limb malformation and often severe mental retardation. RBS arises from 
mutations in ESCO2 that encodes an acetyltransferase and modifies the cohesin subunit 
SMC3. Mutations in SCC2/NIPBL (encodes a cohesin loader), SMC3 or other cohesin 
genes (SMC1, RAD21/MCD1) give rise to a related developmental malady termed 
Cornelia de Lange Syndrome (CdLS). RBS and CdLS exhibit overlapping phenotypes, 
but RBS is thought to arise through mitotic failure and limited progenitor cell 
proliferation while CdLS arises through transcriptional deregulation. Here, I use the 
zebrafish regenerating fin model to test the mechanism through which RBS-type 
phenotypes arise. esco2 is upregulated during fin regeneration and specifically within the 
blastema. Esco2 knockdown adversely affects both tissue and bone growth in 
regenerating fins – consistent with a role in skeletal morphogenesis. Esco2 knockdown 
significantly diminishes cx43/gja1 expression, which encodes the gap junction connexin 
subunit required for cell-cell communication. cx43/CX43 mutations cause the short fin 
(sof b123) phenotype in zebrafish and oculodentodigital dysplasia (ODDD) in humans. 
Importantly, cx43 overexpression rescues esco2-dependent growth defects. These results 
conceptually link ODDD to cohesinopathies and provide evidence that ESCO2 may play 
a transcriptional role critical for human development.    
This work is published as Banerji, R., Eble, D.M., Iovine, M.K. and Skibbens, R.V., 
2016. Esco2 regulates cx43 expression during skeletal regeneration in the zebrafish 
fin. Developmental Dynamics, 245:7-21. Funding: Nemes Fellowship and Lehigh 
University Faculty Innovation Grant. 
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2.2 Introduction 
 The skeleton supports soft tissues, provides for muscle attachment and protects 
internal organs from risk of injury. Additional functions include calcium and phosphorus 
storage, blood cell production and immune response. Given this diverse array of 
functionality, mutations that affect skeletal functions exhibit pleiotropic defects that 
include osteoporosis, osteoarthritis, hematopoietic and immunity deficiencies. 
Aberrations in skeletal development, especially long bone growth and morphogenesis, are 
also components of a number of multi-spectrum developmental abnormalities such as 
Roberts syndrome (RBS) and Cornelia de Lange Syndrome (CdLS).  In addition to severe 
long-bone growth defects and missing digits, both RBS and CdLS patients may exhibit 
craniofacial abnormalities, cleft palate, syndactyly, organ defects and severe mental 
retardation (Liu & Krantz, 2009; Mannini et al, 2010).  
 Recent genetic mapping studies reveal that mutations in cohesion pathways are 
responsible for RBS and CdLS disorders – as well as a host of related diseases 
collectively termed cohesinopathies (Schule et al, 2005; Gordillo et al, 2008; Krantz et al, 
2004; Musio et al, 2006; Tonkin et al, 2004; Vega et al, 2005; Deardorff et al, 2007; 
Deardorff et al, 2012a,b; Van der Lejij et al, 2010; Yuan et al, 2015). Elucidating the 
molecular basis of these disorders span topics of both chromosome segregation and 
transcriptional regulation (Rudra and Skibbens, 2013). For instance, RBS arises from 
mutations in ESCO2. High fidelity chromosome segregation requires that sister 
chromatids be identified from DNA synthesis (S-phase) to anaphase onset during mitosis 
(M-phase). Identity is achieved by cohesin complexes that tether together sister 
chromatids. ESCO2 is an acetyltransferase that converts chromatin-bound cohesins to a 
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tether-competent state (Skibbens et al, 1999; Toth et al, 1999; Ivanov et al, 2002; Zhang 
et al, 2008; Unal et al, 2008; Ben-Shahar et al, 2008). Thus, it is not surprising that cells 
isolated from RBS patients exhibit mitotic failure, elevated levels of apoptosis, reduced 
proliferation and genotoxic hypersensitivities (Mehta et al, 2013; Horsfield et al, 2012). 
On the other hand, CdLS arises from mutations in the cohesin genes SMC1A, SMC3 and 
RAD21, the cohesin deposition factor encoded by NIPBL, and the de-acetylase encoded 
by HDAC8 that targets SMC3 (Krantz et al, 2004; Musio et al, 2006; Tonkin et al, 2004; 
Deardorff et al., 2007; Deardorff et al, 2012a,b). Intriguingly, CdLS patient cells typically 
exhibit normal mitosis and retain a euploid genomic state, revealing that CdLS instead 
arises mainly through transcriptional deregulation (Liu & Krantz, 2009; Dorsett & 
Merkenschlager, 2013). A transcriptional basis of CdLS is supported by findings that 
cohesins are critical for 1) transcription termination, 2) enhancer-promoter registration, 3) 
CTCF-insulator recruitment and 4) RNAPII transitioning from a paused to elongating 
state (Dorsett & Merkenschlager, 2013). Despite the phenotypic similarities between 
RBS and CdLS, the role for ESCO2 in transcription remains undefined. 
 The zebrafish caudal fin contains 16 to 17 segmented bony fin rays with new 
growth occurring by the distal addition of bony segments and associated fin ray joints 
(Goss & Stagg, 1957; Haas, 1962). Because of its simple structure, rapid regeneration 
following amputation, and the ability to knockdown gene expression through gene-
specific morpholinos, the zebrafish fin is emerging as an excellent model system from 
which to elucidate tissue and bone growth pathways. For instance, mutations in 
connexin43 (cx43) cause the short fin (sof b123) phenotype, which is characterized by 
defects in bony fin ray growth and joint formation (Iovine et al, 2005;  Hoptak-Solga et 
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al, 2008). Missense mutations in human CX43 cause Oculodentodigital dysplasia 
(ODDD) - a genetic disorder that effects both craniofacial and distal skeleton limb 
development (Paznekas et al, 2003). Thus, the regenerating fin provides clinically 
relevant insights into highly conserved pathways critical for human skeletal development. 
 Esco2 knockdown studies in zebrafish and medaka embryos produce severe 
developmental defects – in part recapitulating RBS phenotypes (Monnich et al, 2011; 
Morita et al, 2012). Large-scale cell death and subsequent indirect or downstream effects, 
however, complicate interpreting the effects of Esco2 knockdown in these studies. Here, I 
report on the role of esco2 during fin regeneration, in the absence of embryonic 
complications. The regenerating fin is an ideal system to study the effects of reduced 
esco2 on the skeleton in that it avoids the possible confounding effects of reduced esco2 
during development previously reported (Monnich et al., 2011; Whelan et al., 2012). In 
this chapter, sI provide details of results that reveal that esco2 expression is upregulated 
in regenerating fins, particularly in the blastema, which is a specialized compartment that 
contains the majority of proliferative cells. Moreover, Esco2 knockdown results in 
defects in both fin regeneration and bony segment length. Importantly, the results reveal 
that Esco2 knockdown reduces cx43 expression and diminishes Cx43 signaling pathways 
but does not globally reduce other gene expression pathways. In combination, these 
results suggest the possibility that Esco2 may act as a specific transcriptional regulator 
with targets that include cx43. 
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2.3 Materials and methods 
Statement on the ethical treatment of animals 
 This work was carried out in strict accordance with the recommendations in the 
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. 
Lehigh’s Institutional Animal Care and Use Committee (IACUC) (Protocol identification 
# 128, approved 11/16/2014) approved the protocols used for this manuscript. Lehigh 
University’s Animal Welfare Assurance Number is A-3877-01. All experiments were 
performed to minimize pain and discomfort. 
 
Housing and husbandry  
Zebrafish (Danio rerio) are housed in a re-circulating system built by Aquatic 
Habitats (now Pentair). Both 3L tanks (up to 12 fish/tank) and 10L tanks (up to 30 
fish/tank) are used. The fish room has a 14:10 light:dark cycle. Room temperature (RT) is 
tightly regulated and varies from 27-29°C (Westerfield, 1993). Water quality is 
monitored automatically and dosed to maintain conductivity (400-600 µs) and pH (6.95-
7.30). Nitrogen levels are maintained by a biofilter. A 10% water change occurs daily. 
Recirculating water is filtered sequentially through pad filters, bag filters, and a carbon 
canister before circulating over UV lights for sterilization. Fish are fed three times daily, 
once with brine shrimp (hatched from INVE artemia cysts) and twice with flake food 
(Aquatox AX5) supplemented with 7.5 % micropellets (Hikari), 7.5 % Golden Pearl 
(300-500 micron, Brine Shrimp direct), and 5 % Cyclo-Peeze (Argent). 
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Zebrafish strains and surgical procedures 
 The zebrafish strains used were wild-type (C32), sof b123 (Iovine & Johnson, 
2000), and Tg(hsp70:miR-133sp pd48) (Yin et al, 2012). Caudal fin amputations, fin 
regeneration and harvesting were done as previously described (Sims et al, 2009; Ton & 
Iovine, 2013; Govindan & Iovine, 2014). Briefly, fish were first anaesthetized in 0.1% 
tricaine solution and their caudal fin rays amputated to the 50% level uisng a sterile razor 
blade and visualized using a dissecting scope. Fin regeneration proceeded until the 
desired time period depending on the type of experiment. At the required time point, the 
regenerated fins were harvested and fixed in 4% paraformaldehyde (PFA) in PBS 
overnight at 4°C. The fins were then dehydrated in 100% methanol and stored at 20°C 
until further use. 
 
Gene knockdown by morpholino injection and electroporation 
 All morpholinos (MOs) used were fluorescein-tagged and purchased from Gene 
Tools, LLC. The MOs were reconstituted in sterile water to a final concentration of 
1mM. The sequences for MOs used are as follows: MO targeted against esco2 (esco2-
MO: 5'-CTCTTTCGGGATAACATCTTCAATC-3', from Monnich et al., 2011), esco2 -
5-base mismatch control MO (esco2-MM: 5'-CTCTTTCCGCATAAGATGTTGAATC-
3', and Gene Tools standard control MO (5'-CCTCTTACCTCAGTTACAATTTATA-3'). 
Microinjection and electroporation procedures were carried out as described previously 
(Thummel et al, 2006; Hoptak-Solga et al, 2008; Sims et al, 2009). Briefly, caudal fins 
were amputated at 50% level. At 3 days post amputation (3 dpa), fish were anaesthetized 
and MOs injected using a Narishige IM 300 Microinjector. Approximately 50 nl of MO 
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was injected per ray into either the dorsal or ventral side of the regenerating fin tissue 
(approximately first 5 - 6 bony fin rays), keeping the other side uninjected. The 
uninjected side served as the internal control. Immediately after injection, both sides of 
the fin were electroporated using a CUY21 Square Wave electroporator (Protech 
International Inc). To minimize non-specific effects of the electroporation procedure, 
both sides of the fin were electroporated. The following parameters were used during 
electroporation: ten 50-ms pulses of 15 V with a 1 s pause between pulses. These fish 
were returned back to the system water for regeneration to proceed. After 24 hours (i.e. 1 
day post electroporation (1 dpe), which is equivalent to 4 dpa, the injected side of the fins 
were evaluated by fluorescence using a Nikon Eclipse 80i Microscope (Diagnostic 
Instruments) to confirm MO uptake. The MO injected fins were evaluated for regenerate 
length, segment length, cell proliferation, cell death, in situ hybridization, and protein 
levels by western blots and RNA levels by qRT-PCR. For fins used for lysate preparation 
or for qRT-PCR, all fins were injected and electroporated prior to harvesting. 
 
Regenerate length and segment length measurement and analysis 
 At 4 dpe/7 dpa, MO injected (esco2-MO or esco2-MM) fins were calcein stained 
prior to measuring regenerate length and segment length (Du et al, 2001; Sims et al, 
2009). Briefly, fish were allowed to swim for 10 minutes in 0.2% calcein (pH 7) at room 
temperature followed by swimming in fresh system water for another 10 minutes. The 
fish were anaesthetized and imaged using Nikon Eclipse 80i Microscope equipped with a 
SPOT-RTKE digital camera (Diagnostic Instruments) and SPOT software (Diagnostic 
Instruments). All measurements were performed on the longest fin ray (3rd fin ray) from 
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the ventral or dorsal most lobe of the caudal fin, as previously established (Iovine & 
Johnson, 2000). Images used to measure regenerate length and bone segment length were 
analyzed using Image Pro software. For fin regenerate length, measurements were based 
on amputation site to the distal tip of the 3rd fin ray. For bone segment length, the 
distance between the first two joints formed following regeneration was measured. For 
each experiment at least 6-8 fish were used per trial and at least 3 independent trials were 
performed. Student’s t-test (P < 0.05) was used for statistical analysis.  
 
RNA probe preparation and in situ hybridization on whole mount and 
cryosectioned fins 
 RNA probes were made using linear PCR product as template, where the T7 RNA 
polymerase-binding site was included in the reverse primer. The cx43 template was made 
as described (Iovine et al, 2005). The esco2 product was generated using gene-specific 
primers (forward primer- 5’AGCAGGGACCTTCTACAGCA3’and reverse primer 
5’TAATACGACTCACTATAGGGGGGATCATCTGGAAGAACG3’). RNA probes 
were labeled with digoxygenin (DIG) following manufacturer instructions (Roche). In 
situ hybridization (ISH) was performed on wild-type (WT) fins of different time points 
(1, 3, 5 and 8 dpa) and 5 dpa sof b123 fins. Briefly, fins were amputated at 50% level and 
harvested at the appropriate time point. For ISH on knockdown fins, MO (esco2-MO or 
esco2-MM) was injected and electroporated on WT-3 dpa fins and harvested after 24 
hours (1 dpe/4 dpa). For ISH on whole mount fins the standard protocol was followed 
(Ton & Iovine, 2013; Govindan & Iovine, 2014). Note that for ISH on transgenic 
hsp70:miR-133sp pd48- positive and negative fins, at 3 dpa fish were heat shocked at 37˚C 
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for 1 hour and harvested after 24 hours (1 dpe/4 dpa). For all ISH experiments, 
approximately 6-8 fins were used per trial and 3 independent trials were performed. A 
Nikon Eclipse 80i Microscope equipped with a SPOT-RTKE digital camera (Diagnostic 
Instruments) and SPOT software (Diagnostic Instruments) was used to acquire images. 
 ISH on sections was done as described with the following modifications (Smith et 
al, 2008). WT-5 dpa fins were first rehydrated sequentially by methanol-PBS washes, 
cryosectioned and stored at -20°C. Slides were defrosted for approximately 1 hour prior 
to hybridization and section locations marked with a hydrophobic barrier pen (ImmEdge 
Pen; PAP pen, VWR Laboratories). RNA probe was mixed with hybridization buffer: 1X 
salt solution (NaCl, Tris HCl, Tris Base, Na2HPO4, and 0.5 M EDTA), 50% deionized 
formamide (Sigma), 10% dextran sulfate, 1 mg/ml tRNA, and 1X Denhart’s (Fisher) and 
denatured by incubating at 70°C for 5 minutes. The denatured probe mix was added to 
the sections and hybridized overnight at 65°C. Slides were washed at 65°C with a 1X 
SSC, 50% formamide and 0.1% Tween-20 solution, rinsed with MABT (100mM Maleic 
acid, 150mM NaCl, and 0.1% Tween-20) and incubated in a blocking solution (MABT, 
goat serum and 10% milk) for 2 hours. Anti- DIG antibody (1:5000) was diluted in 
MABT and the slides were incubated overnight at 4°C. Slides were washed 4X in 
MABT, 2X in Alkaline Phosphatase staining buffer (100mM Tris, pH 9.5, 50mM MgCl2, 
100mM NaCl, and 0.1% Tween-20), then incubated overnight at 37°C in 10% polyvinyl 
alcohol staining solution and NBT/BCIP stock solution (Roche). The reaction was 
stopped by washing extensively with PBST. Sections were mounted in 100% glycerol 
and images acquired using a Nikon Eclipse 80i Microscope equipped with a SPOT-
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RTKE digital camera (Diagnostic Instruments) and SPOT software (Diagnostic 
Instruments).  
 
Immunoblotting and Esco2 antibody   
 Escherichia coli lysates from cells expressing either GST or GST-Esco2 fusion 
protein (protein expression was induced using 0.3mM IPTG for 4 hours) were prepared 
as described (Gerhart et al, 2012). Briefly, cells from 1 ml of culture were pelleted and 
lysed using 50µg/ml lysozyme in lysis buffer (100mM Tris- HCl pH 7.5, 50 mM NaCl, 
10mM EDTA pH 8, complete protease inhibitor cocktail, Roche). To this mixture, 2.2 N 
NaOH and 8% BME were added. Protein precipitation was carried out using 55% TCA 
followed by wash with 0.5% TCA. The protein pellets were resuspended in 2X SDS 
buffer. GST or GST-Esco2 were detected by western blot using anti-GST antibody (Santa 
Cruz, 1:5000) or affinity-purified anti-Esco2 (1:1000). Affinity purified polyclonal Anti-
Esco2 was generated in rabbit against the N-terminal peptide LSRKRKHGSPDAESC 
(Genscript) and used at a concentration of 1:1000 for the non-competed western blot. For 
anti-Esco2 antibody specificity assay, identical gels were loaded with decreasing volumes 
of the GST-Esco2 protein samples. For the competed blot, the anti-Esco2 antibody was 
pre-incubated with the Esco2 peptide (100µM). The blots were incubated with primary 
antibody overnight at 4˚C.  
 Fin lysates were prepared as previously described (Hoptak-Solga et al, 2008; 
Gerhart et al, 2012; Govindan & Iovine, 2014). Briefly, approximately 9-10 MO-injected 
(esco2 MO or esco2 MM) 1 dpe/4 dpa regenerating fins were pooled, and then suspended 
in incubation buffer (136.8 mM NaCl, 5.36 mM KCl, 0.34 mM Na2HPO4, 0.35 mM 
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KH2PO4, 0.8 mM MgSO4, 2.7 mM CaCl2, 20 mM HEPES with pH adjusted to 7.5) 
supplemented with protease inhibitor (Thermo scientific, HaltTM Protease and 
Phosphatase Inhibitor Cocktail, 100X). The harvested fin tissue was homogenized by a 
tissue homogenizer (Bio-Gen, PRO 200) at high speed (3X) for 5 seconds with 10 second 
cooling intervals. Homogenized samples were centrifuged at 200g for 10 min at 4°C and 
supernatant protein levels normalized according to Bradford assays. Note that for 
preparation of proteins lysate from heat shocked Tg(hsp70:miR-133sp pd48) – positive and 
Tg(hsp70:miR-133sp pd48) –negative fish, 37˚C heat shock was performed for 1 hour at 3 
dpa and fins harvested at 1 dpe/4dpa as previously described.   
 GST, Esco2, Cx43 or tubulin was detected using anti-GST (1:5000) (Santa Cruz), 
anti- Esco2 (1:1000), anti-Cx43 (1:1000) or anti-α-tubulin (1:1000) (Sigma), followed by 
exposure to peroxidase-conjugated goat anti-rabbit IgG (GST, Esco2 and Cx43) or goat 
anti-mouse IgG (tubulin) (Pierce Rockford, IL) at a concentration of 1:20,000. Signal 
detection was performed using ECL chemiluminescent reagent (SuperSignal West Femto 
Maximum Sensitivity Substrate, Pierce Rockford, IL) and X-ray film.  
 Image J software was used to calculate the band intensities and the percent change 
was calculated. Relative pixel densities of gel bands were measured using a gel analysis 
tool in ImageJ software as described (Bhadra and Iovine, 2015). The density of each band 
was obtained as the area under the curve using the gel analysis tool. For relative density 
calculation, the density of the Esco2, Cx43 or tubulin bands for the experimental sample 
was first normalized against the density of the Esco2, Cx43 or tubulin bands from the 
control sample. Relative pixel density was calculated as the ratio of Esco2 and tubulin or 
Cx43 and tubulin, where tubulin is the loading control. 
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Cell proliferation and cell death assays 
 For detection of proliferating cells in S-phase, bromodeoxyuridine (5-bromo-2'-
deoxyuridine, BrdU) labeling was performed with few modifications (Nechiporuk & 
Keating, 2002, Iovine et al, 2005). Briefly, 3 dpa MO injected (esco2-MO or esco2-MM) 
fish were allowed to swim for 5 minutes in 50µg/ml of BrdU (Roche) mixed in system 
water at 1 dpe/4 dpa and harvested on the same day. The BrdU-labeled fins were fixed in 
4% PFA overnight at 4°C and then dehydrated by keeping in 100% methanol overnight. 
Before use, the fins were rehydrated gradually in a series of methanol solutions 
containing 0.1% Triton X-100 in PBS (PBTx). Next, fins were treated for 30 minutes in a 
solution containing 2N HCl in PBTx. Following that, the fins were blocked for 2 hours 
(0.25% BSA in PBTx). The primary antibody against BrdU (Roche) is a mouse 
monoclonal and used at a 1:50 dilution and incubated overnight at 4°C. Extensive washes 
(4 hours) in the PBTx solution were performed the next day and fins incubated overnight 
at 4°C in 1:200 dilution of anti-mouse antibody conjugated to Alexa-546 (Invitrogen). 
The next day extensive washes (4 hours) were performed and the fins mounted in 100% 
glycerol and visualized under a Nikon Eclipse 80i Microscope equipped with a SPOT-
RTKE digital camera (Diagnostic Instruments) and SPOT software (Diagnostic 
Instruments). For measuring BrdU labeled cells the Image Pro software was used. A ratio 
of distance migrated by BrdU positive cells from the regenerating tip in µm (a) and the 
regenerating length in µm (b) was calculated. BrdU labeling was then obtained by 
measuring a/b ratio of the uninjected and injected (esco2-MO and esco2-MM) side of the 
fin.  
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 For both histone-3-phosphate (H3P) and Terminal deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL) assays, 3 dpa MO-injected (esco2-MO or esco2-MM) 
fins were harvested at 1 dpe/4 dpa and fixed in 4% PFA overnight at 4°C. These fins 
were then dehydrated in 100% methanol overnight before use. In order to detect mitotic 
cells, H3P staining and the number of H3P positive cells per unit area were carried out as 
described previously (Ton & Iovine, 2013). The primary and secondary antibodies used 
for H3P assay are as follows: rabbit anti-histone-3-phosphate (1:200) (anti-H3P, 
Millipore) and anti-rabbit Alexa 546 (1:200) (Invitrogen). H3P- positive cells were 
counted without software from within the distal-most 250μm of the 3rd fin ray as 
previously established (Iovine et al, 2005; Hoptak-Solga et al, 2008). 
 TUNEL assay (ApopTag Kit, Chemicon) was performed as described in the 
manufacturer’s instructions with the following modifications. The fins were rehydrated 
by successive washes in methanol/PBST, treated with proteinase K at a concentration of 
5µg/ml for 45 minutes at room temperature, and then re-fixed in 4% PFA in PBS for 20 
minutes. After extensive PBST washes, fins were incubated in ethanol: acetic acid (2:1, 
v: v) at -20°C for 10 minutes. Following extensive PBST washes, fins were incubated in 
equilibrium buffer (from ApopTag Kit) for 1 hour at room temperature, and then 
incubated overnight in 37°C water bath in TdT solution. The enzymatic reaction was 
stopped by extensive washes in stop/wash buffer for 3 hours in 37°C water bath, briefly 
rinsed in PBST and blocked with blocking solution (from ApopTag Kit) for 1 hour. The 
fins were incubated overnight at 37° in Rhodamine antibody solution (from ApopTag 
Kit). Fins were washed extensively in PBST and then mounted in 100% glycerol. Image 
acquisition was performed using a Nikon Eclipse 80i microscope equipped with a SPOT-
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RTKE digital camera (Diagnostic Instruments) and SPOT software (Diagnostic 
Instruments). Cell death was analyzed by counting the number of TUNEL-positive cells 
without software from the distal-most 250 μm of the 3rd fin ray, similar to the H3P-
positive cell counting analysis. For all the experiments at least 6-8 fins were used per trial 
and at least 3 independent trials were performed. Student’s t-test (P < 0.05) was used for 
statistical analysis.  
 
Quantitative real- time PCR analysis 
 Quantitative real- time PCR analysis (qRT-PCR) was completed on total mRNA 
extracted from 1 dpe/4 dpa harvested fins (3 dpa esco2-MO and standard control-MO 
injected). Total RNA extraction was carried out by following the standard protocol (Sims 
et al, 2009). Briefly, Trizol reagent (Gibco) was used to extract mRNA from minimum of 
10 fins. For making cDNA, 1μg of total RNA was reverse transcribed with SuperScript 
III reverse transcriptase (Invitrogen) using oligo (dT) primers. The following primers 
(2.5µM) for keratin, cx43 (Sims et al, 2009), sema3d (Ton & Iovine, 2013), hapln1a 
(Govindan & Iovine, 2014), and mps1 (Bhadra & Iovine, 2015) were used for qRT-PCR 
analysis. The primers for shh and spry4 were designed using Primer express software 
(shh: forward primer: 5’-GGCTCATGACACAGAGATGCA-3’, reverse primer: 5’- 
CATTACAGAGATGGCCAGCGA-3’ and spry4: forward primer: 5’- 
CGCAACGACCTGTTCATCTGA-3’, reverse primer: 5’- 
GCACTCTTGCATTCGAAAGCA-3’). Data from three independent Esco2 knockdown 
RNA samples were used, with qRT-PCR for each gene performed in duplicate, for 
comparison between experimental treatments. RNA and subsequent cDNA synthesized 
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from standard control MO injected fins served as the control. The standard control MO 
does not target any zebrafish genes. Analyses of the samples were done using Rotor-Gene 
6000 series software (Corbette Research) and the average cycle number (CT) determined 
for each amplicon. Keratin was used as a housekeeping gene, and the delta CT (ΔCT) 
values represent expression levels normalized to keratin values. ΔΔCT values represent 
the relative level of gene expression and the fold difference was determined using the 
ΔΔCT method (2-ΔΔ CT) as described (Ton and Iovine, 2013). Standard deviation was 
calculated using the comparative method described in User Bulletin 2 # ABI PRISM 
7700 Sequence Detection System 
(http://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/generaldocum
ents/cms_040980.pdf). 
 
Heat shock induction of cx43 expression  
Tg(hsp70:miR-133sp pd48) are denoted as transgene-positive (Tg+) and their 
siblings denoted as transgene-negative (Tg-) were used in the heat shock experiment (Yin 
et al, 2012). For all the experiments at least 6-8 fish were used per trial and at least 3 
independent trials were performed. Esco2 knockdown was performed on 3dpa Tg+ and 
Tg- fish as described above. After 4 hours both groups were heat shocked at 37ºC for 1 
hour and returned to the system water for recovery. Tg+HS+ and Tg-HS+ denoted these 
groups respectively. To confirm that rescue depended on cx43, we also examined 
phenotypes in the transgenic line without heat shock (Tg+HS-). Induction of the 
transgene expression upon heat shock was confirmed after 24 hours by screening for 
GFP-positive fins in the Tg+HS+ group. The control groups (Tg-HS+ and Tg+HS-) were 
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negative for GFP expression after heat shock. For measurement of regenerate length and 
segment length fins were harvested at 4 dpe/7 dpa and calcein stained as previously 
described (Du et al, 2001; Sims et al, 2009). The measurement and data analysis were 
done as described below. Image acquisition was carried out by using the Nikon Eclipse 
80i microscope equipped with a SPOT-RTKE digital camera (Diagnostic Instruments) 
and SPOT software (Diagnostic Instruments). Image Pro software was used for 
regenerate and segment length measurements.  
To evaluate the regenerate length and segment length of Tg(hsp70:miR-133sp pd48) 
fins,  the esco2-MO injected side of each fin was compared to its un-injected side by % 
similarity method as described (Bhadra and Iovine, 2015). Briefly, the length of the 
injected side and uninjected sides were measured in µm and denoted as A and B 
respectively. The % similarity for each fin was calculated by using the formula: [(A/B) x 
100]. Values close to 100% indicate that the esco2-MO has no effect on the phenotype 
whereas a value less than 100% indicate that the MO has an effect on the observed 
phenotype. The mean of % similarity for the Esco2 knockdown experimental group 
(Tg+HS+) and the corresponding Esco2 knockdown control groups (Tg-HS+ and 
Tg+HS-) were estimated and compared, and the statistical significance between the 
groups was determined using two-tailed unpaired student's t-test (P < 0.05). Segment 
length analysis was performed on calcein stained fins. Briefly, for segment length, the 
distance between the first two newly formed joints following amputation was measured 
(in the 3rd fin ray from either the dorsal or ventral end) since that was previously 
established as a standard (Iovine & Johnson, 2000). To evaluate the phenotypic effect of 
segment length, the % similarity method was used as described above.  
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2.4 Results 
esco2 mRNA is upregulated in the blastema of regenerating fins 
 Despite the fact that ESCO2 is critical for proper human development (Schule et 
al, 2005; Vega et al, 2005), little information exists regarding its expression or the 
molecular basis through which mutations in ESCO2 result in skeletal disorders. Here, I 
exploit the adult zebrafish regenerating fin to address both of these fundamental issues in 
the absence of confounding effects due to embryonic death. To ascertain the temporal 
regulation of esco2 expression in regenerating fins, fins were amputated at the 50% level 
and regenerating tissue harvested at 1, 3, 5 and 8 days post amputation (dpa). The 
expression of esco2 was then assessed by whole mount in situ hybridization (Figure 2.1). 
At 1 dpa, esco2 was not detectable. esco2 was readily apparent at both 3 and 5 dpa with 
levels starting to diminish at this later time point.  By 8 dpa, esco2 expression was 
significantly reduced. High esco2 expression at 3 dpa is consistent with previous studies 
that map this period as the peak rate of regeneration in the zebrafish fin (Hoptak-Solga et 
al, 2008; Lee et al, 2005) and suggest that the localization of esco2 expression might 
similarly correlate with the highly proliferative blastemal compartment. To test this 
possibility, 5 dpa fins stained for esco2 expression by in situ hybridization were 
cryosectioned. The results reveal that esco2 expression is specifically upregulated in the 
blastemal compartment (Figure 2.2). To establish that the probe had access to all esco2-
positive tissue, 5 dpa fins were cryosectioned prior to hybridization (Smith et al, 2008). 
Results from this regimen confirm that esco2 is expressed specifically within the 
blastema (Figure 2.2). In summary, esco2 expression is temporally regulated and occurs 
specifically in the blastemal compartment of the zebrafish regenerating fin. 
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esco2 is a critical regulator of fin regeneration and specifically of bone growth 
 Esco2 is likely essential (Monnich et al, 2011), requiring knockdown strategies to 
ascertain function in the adult regenerating fin. Therefore, I depleted Esco2 using 
morpholino (MO)-mediated knockdown methodologies (Hoptak-Solga et al, 2008; Sims 
et al, 2009) using one of the two validated MOs for Esco2 (Monnich et al, 2011). As a 
control I used either a custom mismatch morpholino (5MM) containing five mismatches 
compared with the esco2 targeting MO or the ‘standard control’ MO from Gene Tools 
that does not recognize target genes in zebrafish. Uptake is accomplished by first 
injecting the MO into the blastema of the regenerating fin, followed by electroporation 
across the fin. All MOs are modified with fluorescein, permitting validation of cellular 
uptake. Only fins positive for MOs at 1 day post electroporation (dpe) are kept for further 
analysis. Procedural details for all knockdown experiments are outlined in Figure 2.3.  
 Regenerate length and segment length were evaluated at 4 dpe/7 dpa. All fin 
regenerate and segment length measurements were obtained from the 3rd fin ray and 
results compared between injected (esco2-MM or esco2-MO) and uninjected portions of 
the same fin, a strategy previously documented as providing for both internal controls and 
standardized analyses (Hoptak-Solga et al, 2008; Iovine & Johnson, 2000). Uninjected 
control fins regenerated in a robust fashion. esco2-MM injected regenerating fins 
exhibited identical growth to the uninjected control (Figure 2.4). In contrast, regenerating 
fins injected with the esco2-MO exhibited a significant decrease in regenerate length 
compared to uninjected controls within the same fins (Figures 2.4), documenting that 
esco2 is critical for fin regeneration.  
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 Roberts syndrome patients exhibit significant bone growth deficiencies - 
especially in the arms and legs (Mehta et al, 2013; Horsfield et al, 2012). Thus, it became 
important to quantify the extent that esco2 depletion may specifically impact bone 
segment growth in regenerating fins. To address this question, segment length was 
measured in uninjected, esco2-MM and esco2-MO injected fins. The results show that 
segment length in uninjected fish was nearly identical to that of esco2-MM injected fish 
(Figure 2.4). However, segment length was significantly reduced in esco2-MO injected 
fish compared to the uninjected side of the same fish fins (Figure 2.4). Thus, esco2 is 
critical for bone growth in regenerating fin, consistent with its role in skeletal 
development in humans. 
 To confirm that the esco2-MO was effective in reducing Esco2 protein levels, I 
generated an antibody against Esco2 and verified its specificity using bacterial lysates 
expressing GST-Esco2. The results show that anti-Esco2 antibody recognizes GST-
Esco2, which migrates at the predicted size of 94 kDa. The anti-GST antibody also 
recognizes the GST-Esco2 band at the predicted size of 94 kDa and a 26 kDa band in the 
GST alone lane (Figure 2.5). The anti-Esco2 antibody does not recognize GST alone. To 
confirm the specificity of the anti-Esco2 antibody, a peptide competition assay was 
performed. Esco2-directed antibody was pre-incubated with the peptide that the antibody 
was generated against. The resulting competed antibody produced a greatly reduced 
signal, compared to non-competed antibody, when used to detect GST-Esco2, confirming 
antibody specificity (Figure 2.5). Upon validating the specificity of the Esco2-directed 
antibody, I tested the effectiveness of the esco2-MO to knockdown Esco2 levels in vivo. 
At 3 dpa, fins were injected with either esco2-MM or esco2-MO and harvested the next 
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day (1 dpe/4 dpa) to prepare fin lysate (see also Figure 2.3). The lysates were used to test 
for Esco2 reduction by western blot. Quantification of the resulting western blots shows 
that the esco2-MO reduces Esco2 protein levels by approximately 70% while robust 
levels of Esco2 persist in MM injected fins (Figure 2.5). The results of the Western blot 
analyses document the efficacy of the esco2-MO to significantly reduce Esco2 protein 
levels.  
 
Role of esco2 in cell proliferation and programmed cell death  
 Reduced tissue and bone segment growth in regenerating fins could be due to 
decreased cell proliferation, increased programmed cell death (PCD), or both. In order to 
address possible changes in the level of cell proliferation, I evaluated both 5-bromo-2'-
deoxyuridine (BrdU) as a marker for S-phase (Iovine et al, 2005) and histone-3-
phosphate (H3P) as a marker for M phase (Wei et al, 1999). Morpholino-injected fish 
(where half of the fin was injected with either esco2-MO or esco2-MM, see also Figure 
2.3) were allowed to swim in water supplemented with BrdU at 1 dpe/4 dpa and 
harvested on the same day. To quantify BrdU staining through which BrdU incorporation 
could be directly compared between the two fin halves, I compared the ratio of the BrdU-
positive domains in the regenerating tip to the total regenerate length. As expected, 
esco2-MM injected and uninjected fins exhibited nearly identical ratios of BrdU labeled 
cells to regenerate fin length. In contrast, esco2-MO injected and uninjected sides 
produced a significant decrease in the ratio of BrdU labeled cells to regenerate length 
(Figure 2.6). Next I evaluated H3P-positive cells at 1 dpe/4 dpa (see also Figure 2.3). To 
compare H3P-positive cells between esco2-MM and MO injections in fin halves of the 
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same fine, I counted the total number of H3P-positive cells in the 250 mm area that 
defines the proliferative blastema, normalizing for the area (Nechiporuk et al, 2003). 
Regenerating fins in which one fin half was uninjected and the other half injected with 
esco2-MM exhibited nearly identical numbers of H3P-positive cells within this defined 
area (Figure 2.6). In contrast, the esco2 MO-injected side exhibited a statistically 
significant reduced level of H3P-staining cells compared to the uninjected sides of the 
fins (Figure 2.6). Thus, cell proliferation appears to play a critical role in skeletal 
regrowth defects that occur in regenerating fins depleted of Esco2.  
 To address the possibility that PCD is increased in Esco2 depleted fins, fins were 
injected with either esco2-MM or esco2-MO on one half of the fin, the other half 
uninjected, and the fins were harvested 1 dpe/4 dpa for TUNEL staining (see also Figure 
2.3). Importantly, I did not detect a noticeable difference in the number of TUNEL-
positive cells between the esco2-MO injected side and the uninjected side of the same 
fins (Figure 2.7). Statistical analysis confirms that similar numbers of apoptotic cells are 
present in Esco2 knockdown and uninjected sides of the same fins (Figure 2.7). Thus, it 
appears, that regenerate and bone growth defects that occur upon Esco2 knockdown can 
be separated from increased levels of PCD.  
 
esco2 and cx43 appear to function in a common pathway 
 The pattern of esco2 expression and localization during fin regeneration, coupled with 
impact of esco2 depletion on bone segment regrowth, are strikingly similar to those previously 
reported for cx43 mutations that cause the short fin (sof b123) phenotype (Iovine et al, 2005; 
Hoptak-Solga et al, 2008). Could Esco2 and Cx43 function in a common pathway to influence 
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bone segment growth?  To address this possibility, I first tested whether Esco2 function is 
downstream of Cx43. If true, then esco2 expression might be reduced in sof b123 mutant fins. 
Whole mount in situ hybridization was performed to monitor esco2 message levels in wild type 
(WT) and sof b123 regenerating fins. The results show that esco2 expression levels are nearly 
identical in regenerating WT and sof b123 fins (Figure 2.8), suggesting that esco2 is not 
downstream of cx43. An alternate possibility is that cx43 is downstream of esco2. Whole mount 
in situ hybridization was performed on Esco2 knockdown fins (1 dpe/4 dpa, see also Figure 2.3) 
to determine if cx43 expression is reduced in the half of the fin injected with esco2-MO (Figure 
2.9). Indeed, cx43 was reduced in fin rays injected with esco2-MO and not reduced in either 
MM control or uninjected controls (Figure 2.9). To independently test for cx43 dependency on 
esco2, I performed qRT- PCR at 1 dpe/4 dpa (see also Figure 2.3). The results from 3 
independent Esco2 knockdown samples show that cx43 is significantly down regulated in Esco2 
knockdown regenerating fins (Table 2.1; Figure 2.10). Since reduced cell proliferation is not 
sufficient to cause reduced cx43 expression (Govindan & Iovine, 2014; Bhadra & Iovine, 2015), 
the observed reduction of cx43 expression is not likely the result of reduced cell proliferation in 
Esco2 knockdown fins. In combination, these findings support a model where Cx43 acts 
downstream of, and may be regulated by, Esco2.  
 To further examine the possibility that Esco2 and Cx43 function in a common 
pathway, I next evaluated expression of both semaphorin3d (sema3d) and hyaluronan 
and proteoglycan link protein 1a (hapln1a), two genes recently found to function 
downstream of cx43 (Ton & Iovine, 2013; Govindan & Iovine, 2014). If esco2 is required 
for cx43 expression, then esco2 depletion should also repress these cx43 targets. I 
examined the expression levels of sema3d and hapln1a using qRT-PCR on 3 dpa 
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regenerating fins injected with esco2-MO compared to the standard control morpholino. 
The results show that both sema3d and hapln1a are significantly down regulated in MO-
injected regenerating fins (Table 2.1; Figure 2.10), consistent with the model that Esco2 
regulates Cx43 signaling pathways that are critical for development. To exclude the 
possibility that Esco2 depletion represses all gene expression, I evaluated expression 
levels of three genes not known to be cx43-dependent, sonic hedgehog (shh), sprouty 4 
(spry4) and mono polar spindle (mps1) (Laforest et al, 1998; Lee et al, 2005; Poss et al, 
2002). Expression levels of these genes are not reduced, demonstrating that Esco2 
depletion does not lead to global gene repression. Both shh and spry4 appear to be 
modestly upregulated, which could suggest either that Esco2 antagonizes these genes or 
that Esco2-dependent disruption of cell proliferation indirectly affects gene expression in 
these pathways. In combination, these results reveal that Esco2 acts as a transcriptional 
regulator with targets that include cx43. 
 If cx43 truly acts downstream of Esco2 and cx43 reduction in part mediate the 
bone growth defects observed upon Esco2 knockdown, then I reasoned that cx43 
overexpression might attenuate the regenerate and bone segment growth defects in 
regenerating fins. To test this prediction, I next attempted to rescue esco2-dependent 
skeletal growth defects by overexpression of cx43. I utilized the Tg(hsp70:miR-133sp 
pd48) line that harbors an EGFP cDNA followed by three miR-133 binding sites (Ebert et 
al, 2007; Loya et al, 2009).  Prior studies found that miR-133 knockdown via this 
“sponge” transgene increases cx43 levels during zebrafish heart regeneration (Yin et al, 
2012). I confirmed upregulation of both cx43 mRNA and Cx43 protein in regenerating 
fins of this transgenic line treated for heat shock (Figure 2.11). Moreover, to rule out the 
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possibility that increased Cx43 leads to an increase in Esco2, I further confirmed that the 
levels of esco2 mRNA and Esco2 protein are not upregulated in this transgenic line 
treated for heat shock (Figure 2.11). 
 Either transgenic-positive (Tg+) or transgenic-negative (control siblings, Tg-) fins 
were treated for Esco2 knockdown (Figure 2.12). Four hours post electroporation, Tg+ 
and Tg- fish were both heat shocked (HS+) at 37˚C for 1 hour. These fish are denoted as 
Tg+HS+ and Tg-HS+, respectively. Alternatively, a second group of Esco2 knockdown 
Tg+ fish was not heat shocked and thus denoted as Tg+HS-. To demonstrate that heat 
shock alone does not rescue esco2-dependent phenotypes, I performed Esco2 knockdown 
in Tg-HS+. Results from 3 independent trials show that Esco2 knockdown in Tg-HS+ 
exhibited the predicted growth defects for regenerate fin and bone segment lengths (i.e. 
the percent similarity between the Esco2 knockdown side and the uninjected side is low) 
(Figure 2.12). In contrast, Esco2 knockdown followed by induction of the transgene 
(causing cx43 over-expression) in Tg+HS+, exhibited increased regenerate length and 
segment length, demonstrating Cx43-dependent rescue of the Esco2 knockdown 
phenotypes (i.e. the percent similarity between the Esco2 knockdown side and the 
uninjected side is significantly increased when cx43 is overexpressed). I performed the 
same experiment using esco2-MM construct as a negative control. As expected, I did not 
observe skeletal phenotypes in these fins (data not shown).  In order to demonstrate that 
the rescue of phenotype is heat shock dependent and therefore requires overexpression of 
cx43, I performed the same Esco2 knockdown experiment in the absence of heat shock in 
Tg+ fish (Tg+HS-). Importantly, I did not observe rescue of skeletal phenotypes in fish 
that carry the transgene but in which I do not induce its expression via the heat pulse 
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(Figure 2.12). The combination of these experiments provide compelling evidence that 
Esco2 and Cx43 function in a common pathway, and that the observed esco2-dependent 
skeletal phenotypes are at least partially mediated by reduced cx43 expression. 
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2.5 Discussion    
 Cohesinopathies are a growing collection of severe and phenotypically pleiotropic 
developmental maladies, but at present the molecular mechanisms through which cells 
and developing organisms respond to cohesion mutations remains unclear (Mehta et al, 
2013; Horsfield et al, 2012; Dorsett & Merkenschlager, 2013; Barbero, 2013). For 
instance, CdLS appears to arise through transcriptional deregulation that occurs in 
response to heterozygous or X-linked mutations in NIPBL, SMC1, SMC3, RAD21, 
HDAC8 or PDS5 (Krantz et al, 2004; Musio et al, 2006; Tonkin et al, 2004; Deardorff et 
al, 2007; Deardorff et al, 2012a,b; Gillis et al, 2004; Zhang et al, 2009). In contrast, the 
sister cohesinopathy RBS, which arises through homozygous mutation of ESCO2 (Schule 
et al, 2005; Gordillo et al, 2008; Vega et al, 2005), is thought to arise instead through 
reduced progenitor cell proliferation and increased mitotic failure and apoptosis (Mehta 
et al, 2013; Horsfield et al, 2012; Whelan et al, 2012). My current studies suggest that 
Esco2 is a critical and specific transcription regulator – leading us to speculate that RBS 
is most likely a transcriptional deregulation malady. Support for this model is three-fold. 
First, Esco2 knockdown reduces transcription of specific cell signaling pathways such as 
cx43, mutations in which disrupt proper development (Paznekas et al, 2003; Musa et al, 
2009; Iovine et al, 2005), but not other developmentally relevant signaling pathways such 
as shh (Table 2.1; Figure 2.10). Second, recent evidence reveals that Esco2 regulates 
Notch signaling through binding/sequestration of the intracellular Notch domain (Leem et 
al, 2011). Notch is required for neuronal differentiation, skeletal development and 
hematopoietic lineages – consistent with pleiotropic phenotypes that result in both esco2 
and notch mutations (Zanotti & Canalis, 2013). Third, my results reveal no significant 
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increase in the incidence of apoptotic cells following Esco2 knockdown in the blastemal 
compartment of regenerating fins. At present, I cannot exclude the possibility that a small 
increase in apoptotic cells is masked by a low but consistent background level required 
for remodeling in the regenerating fin, but the fact that elevated levels were not 
discernible in MO-injected fins compared to MM-injected and uninjected matched-fin 
controls suggests instead that the effects on fin and bone segment regeneration can occur 
independent of apoptosis. These findings contrast studies involving Esco2 knockdown in 
zebrafish and medaka embryos and mice in which reproducible elevations in apoptotic 
cells were reported (Monnich et al, 2011; Morita et al, 2012; Whelan et al, 2012). 
However, the effects in those studies are modest. ESCO2 knockdown in mice 
neuroeptihelium, for instance, produced severe microcephaly but succeeded in inducing 
only a 2-fold increase in the number of apoptotic cells (Whelan et al, 2012). In zebrafish 
embryos, esco2 depletion resulted in Caspase 8 activation that was temporally limited 
(Monnich et al, 2011). Esco2 depletion also resulted in a 4-fold increase in the number of 
apoptotic cells in zebrafish embryos and global induction of apoptosis in medaka 
embryos, but such increases that occur in inviable or failing embryos are plausibly 
downstream events indirectly coupled to esco2 effects (Monnich et al, 2011; Morita et al, 
2012). Thus, it remains possible that apoptosis is not the major clinically relevant 
etiologic effect of esco2 mutation in RBS patients, especially since apoptosis is not a 
feature of CdLS cells (Tonkin et al, 2004; Castronovo et al, 2009; Revenkova et al, 
2009). I hypothesize that the transcriptional deregulation that arises from ESCO2 
mutations may be the underlying etiologic basis for the developmental abnormalities of 
RBS - upon which are overlaid cohesion defects, mitotic failure and apoptosis.    
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 Currently, mutation of ESCO2 represents the sole etiologic agent of the severe 
developmental disorder Roberts Syndrome (RBS) in humans (Vega et al, 2005). I posit 
that a second revelation from this work is that Esco2 may be an upstream regulator of 
Cx43 function in zebrafish regenerating fins. For instance, esco2 depletion not only 
reduces cx43 expression, but also expression of sema3d and hapln1a, two genes in the 
bone growth signaling pathways that rely upon Cx43. Conversely, genes that appear 
independent of Cx43, such as shh, spry4 and mps1 were not reduced in Esco2 knockdown 
regenerating fins. Notably, the spatial and temporal expressions of esco2 and cx43 are 
nearly identical within the regenerating fin (Iovine et al, 2005). Moreover, the 
demonstration that overexpression of cx43 rescues esco2-dependent skeletal phenotypes 
strongly suggests that Esco2 and Cx43 function in a common pathway. If this model is 
correct that Esco2-dependent expression of Cx43 is an important factor in human 
development, then cx43 mutation should similarly manifest developmental abnormalities.  
In fact, mutations of human CX43 cause Oculodentodigital dysplasia (ODDD), a malady 
that includes craniofacial dysmorphias, distal limb skeletal growth defects and abnormal 
eye and teeth development (Paznekas et al, 2003; Musa et al, 2009). I note prior studies 
in which mutation/depletion of either esco2, nipbl or rad21 were found to impact a 
plethora of developmentally relevant genes, including CX43/GJA1 – observations that 
helped to inform the current work (Monnich et al, 2011; Kawauchi et al, 2009). My 
findings suggest that Esco2 function may be coupled to a Cx43-dependent signaling 
pathway previously shown to directly promote proper development. Based on these 
results, I suggest that ODDD could be a mild form of cohesinopathies.  
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 Conservatively, this work is consistent with a model that Esco2 regulates the 
expression of cx43 and its downstream targets (i.e. sema3d and hapln1a), thereby 
influencing growth and skeletal patterning (Figure 2.13). Future experiments to test this 
model include measuring cx43 expression level in RBS patient cells and directly 
assessing esco2 localization/regulation of the cx43 promoter. Alternatively, the impact of 
Esco2 on the skeleton may occur through its roles in DNA damage repair, DNA 
replication fork progression, chromosome compaction or ribosome maturation/assembly 
(Skibbens et al, 1999; Skibbens et al, 2010; Gard et al, 2009; Bose et al, 2012; Terret et 
al, 2009; Unal et al, 2004; Strom et al, 2004; Gerton, 2012; Skibbens et al, 2013).   
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2.6 Figures 
 
                                
 
Figure 2.1: Time course in situ hybridization of esco2 in whole mount 
regenerating fins. (A) esco2 expression in 1 day post amputated (dpa) regenerating 
fin was largely not detectable. (B) esco2 expression in 3 dpa regenerating fin was 
strongly detected at the distal end and (C) began to gradually decline in 5 dpa 
regenerating fin. (D) Expression of esco2 was reduced in regenerating fin by 8 dpa. 
The amputation plane is indicated by a solid line except in 8 dpa regenerating fin 
(panel D), where it is out of the field of view. Scale bar is 50 µm. 
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Figure 2.2: In situ hybridization of esco2 in fin cryosections. (Left) Cryosection 
from a whole mount wild-type (WT)-5 dpa in situ hybridized fin showing tissue 
specific expression of esco2 mRNA within the blastema compartment. (Right) In situ 
hybridization was completed on a WT-5 dpa fin cryosection showing a similar pattern 
of esco2 expression localized specifically at the blastemal region. Arrows indicate 
esco2 expression at blastema. b- blastema, e- epidermis, m- mesenchyme. Scale bar is 
50 µm. 
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Figure 2.3: Timeline of experimental procedure. Fins were amputated at 50% level 
and allowed to regenerate for 3 days. At 3 dpa, either gene-targeted morpholino or a 
control morpholino (MO) was injected to one half of the regenerating fin, immediately 
followed by electroporation on both sides. After 24 hours,1 day post electroporation (1 
dpe/4 dpa), the fins were evaluated by fluorescence microscopy to confirm MO uptake. 
The fins were harvested at 1 dpe/4 dpa for histone-3-phosphate (H3P) assay, Terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, in situ 
hybridization (ISH), and fin lysate preparation for protein expression by western blot and 
RNA extraction for quantitative real time PCR (qRT-PCR). Note that for protein lysates 
and for qRT-PCR, all fin rays across the fin were injected with morpholino and 
electroporated prior to harvesting at 1 dpe/4 dpa. For 5-bromo-2'-deoxyuridine (BrdU) 
labeling the MO-injected fins were allowed to swim in 50µg/ml of BrdU water for 5 
minutes at 1 dpe/4 dpa and harvested on the same day. For regenerate length and segment 
length analysis fins were allowed to regenerate longer and were calcein stained at 4 dpe/7 
dpa. For each experiment at least 6-8 fish were used per trial and at least 3 independent 
trials were performed.  
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Figure 2.4: Morpholino mediated Esco2 knockdown phenotypes include 
reduction in regenerate length and bone segment length. (A) Representative 
images showing decreased regenerate length in esco2 morpholino (MO) injected half 
compared to the uninjected (UN) half of the same fin. (B) Representative images 
showing similar levels of regeneration in fins injected with esco2 mismatch (MM) 
MO compared to the UN half of the same fin. The red line indicates the amputation 
plane. Arrows indicate the distance from the amputation plane to the distal end of the 
3rd fin ray. (C) Representative images of calcein stained segments of the 3rd fin ray 
show shorter bone segments in MO-injected fin half compared to the UN half of the 
same fin. (D) Representative images of calcein stained segments of the 3rd fin ray of 
MM-injected and UN fins reveal bone segments of similar lengths. For all 
experiments 6-8 fish were used per trial and at least 3 independent trials were 
performed. The MO/MM was injected/electroporated in 3 dpa fins and was allowed 
to regenerate for 4 days. For regenerate length and segment length measurements the 
fins were calcein stained at 4 dpe/7 dpa.  For calcein staining, fish were allowed to 
swim for 10 minutes in 0.2% calcein (pH 7) at room temperature followed by fresh 
system water for another 10 minutes. (E) Graph reveals significant reduction (*) in 
regenerate length in MO treated fins compared to UN fins.  Regenerate length of MM 
treated fins and UN fins show no significant differences in length. (F) Graph shows 
significant reduction (*) in segment length between MO treated fins and UN fins. The 
segment length of MM treated fins and UN fins show no significant difference. 
Student’s t-test was used for determining statistical significance where p < 0.05. Error 
bars represent standard error. Scale bar is 50 µm. 
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Figure 2.5: The Esco2 antibody is specific and MO-mediated Esco2 knockdown 
results in decreased levels of Esco2 protein. (A) Western blot of bacterial lysates 
expressing either GST-Esco2 or GST. Lanes 1 and 4 are lysates of induced GST-
Esco2. Lanes 2 and 5 are lysates of uninduced GST-Esco2. Lanes 3 and 6 are lysates 
of induced GST. When probed with either the anti-Esco2 antibody or an anti-GST 
antibody, a major protein band of the predicted size of 94 kDa (indicated by an 
arrowhead) is detected in the induced GST-Esco2 lysates (lanes 1 and 4), and not in 
the uninduced GST-Esco2 lysates (lanes 2 and 5). Additional bands below 94 kD 
likely represent proteolysis of GST-Esco2. The anti-Esco2 antibody does not detect 
GST alone, which has a molecular weight of 26 kD (compare lanes 3 and 6). (B) Two 
volumes of bacterial lysates expressing GST-Esco2 were loaded in two identical gels. 
Pre-incubation of the anti-Esco2 antibody with the Esco2 peptide (competed lanes a* 
and b*) significantly reduced the antibody binding compared to non-competed 
antibody (lanes a and b). The 94 kDa bands are marked (arrowhead). (C) Western blot 
reveals that anti-Esco2 antibody detects a major protein band at 68 kDa from fin 
lysate prepared from mismatch (MM) control morpholino injected fins and Esco2 
knockdown (MO) fins (1 dpe/4 dpa). The blot confirms the reduction of Esco2 
protein in the knockdown lysate (MO) compared to the control lysate (MM). The 
presence of additional bands in the fin lysates may be due to modification or 
degradation. Tubulin was used as a loading control. The single band marked was used 
for relative band intensity analysis using the gel analysis tool (ImageJ software). 
Similar findings were observed in each of three trials.  
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Figure 2.6: Role of esco2 in cell proliferation. (A) (Top) Representative images of 
BrdU-positive cells in uninjected (UN) and esco2-MO injected (MO) fins. (Bottom) 
Representative images of BrdU-positive cells in uninjected (UN) and MM injected 
fins. Briefly, the MO/MM was injected/electroporated in 3 dpa fins and the next day 
(1 dpe/4 dpa) the fish were allowed to swim in 50µg/ml BrdU water for 5 mins and 
then harvested. For all the experiments at least 6-8 fins were used per trial and at least 
3 independent trials were performed. The arrow indicates the span of the BrdU-
positive cells from the tip of the 3rd fin ray (a) and the bracket indicates total 
regenerate length of the 3rd fin ray (b) The amputation plane is shown by a horizontal 
line. (B) Graph shows the significant reduction (*) in a/b ratio of BrdU-positive cells 
in MO injected fins compared to the UN fins. The difference between the MM treated 
fins and the UN fins is not significantly different. Student’s t-test was used for 
determining statistical significance where p < 0.05. Error bars represent standard 
error. Scale bar is 100 µm. (C) (Top) Representative images of H3P-positive cells in 
uninjected (UN) and esco2-MO injected (MO) fins. (Bottom) Representative images 
of H3P-positive cells in uninjected (UN) and MM injected fins. The arrows indicate 
single H3P-positive cells. At least 6-8 fins were used per trial and 3 independent trials 
were performed. The MO/MM was injected in 3 dpa fins and harvested at 1 dpe/4 
dpa. H3P- positive cells were counted by eye from within the distal-most 250μm of 
the 3rd fin ray as previously established. (D) Graph shows the significant reduction 
(*) in the average number of H3P-positive cells in MO injected fins compared to the 
UN fins. The difference between the MM treated fins and the UN fins is not 
significantly different. Student’s t-test was used for statistical analysis where p < 
0.05. Error bars represent standard error. Scale bar is 50 µm. 
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Figure 2.7: Role of esco2 in programmed cell death. Representative bright-field 
image (A) and TUNEL-positive cells (B) in esco2-MO injected fin. Representative 
bright-field image (C) and TUNEL-positive cells (D) in MM injected fins. At least 6-
8 fins were used per trial and 3 independent trials were performed. The MO/MM was 
injected in 3 dpa fins and harvested at 1 dpe/4 dpa. TUNEL- positive cells were 
counted by eye from within the distal-most 250μm of the 3rd fin ray. The amputation 
plane is shown by a horizontal line and * indicates the individual fin rays. High levels 
of TUNEL-positive cells located at the amputation plane serve as an internal control 
for staining. The box represents the area used to count the cells. (E) Graph shows 
similar average numbers of TUNEL-positive cells in either MO injected fins or the 
MM injected fins, compared to the UN fins. Student’s t-test was used for determining 
statistical significance where p < 0.05. Error bars represent standard error. Bracketed 
comparisons were not significant. Scale bar is 50 µm. 
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Figure 2.8: Expression of esco2 mRNA in wild-type (WT) and short fin (sof b123) 
fins by whole mount in situ hybridization. WT and sof b123 fins were amputated at 
50% level and allowed to regenerate for 5 days. At 5 dpa the fins were harvested. At 
least 6-8 fins were used per trial and 3 independent trials were performed. (Left) 
Whole mount in situ hybridization (ISH) on WT-5 dpa regenerating fin showing 
esco2 expression. (Right) Whole mount ISH on sof b123 -5 dpa regenerating fins 
shows similar expression levels of esco2. The brackets represent the zone of esco2 
expression. Scale bar is 50 µm. 
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Figure 2.9: In situ hybridization on morpholino mediated Esco2 knockdown fins 
shows reduced levels of cx43 expression. The MO/MM was injected in 3 dpa fins 
and fins were harvested at 1 dpe/4 dpa. Black lines identify the amputation plane 
unless it is out of the field of view (i.e. as occurs in most of the higher magnification 
images). The fin in panel A appears curved since there was less growth on the Esco2 
knockdown side compared with the uninjected side. (A) (Top) Representative image 
of a fin with Esco2 knockdown side (esco2 MO) showing decreased staining of cx43, 
compared to the uninjected side (UN). Bottom left- Higher magnification of the 
knockdown side (MO) of the same fin (fin rays from top image marked by *) 
showing reduced cx43 expression. (Bottom right) Higher magnification of the 
uninjected side (UN) of the same fin (fin rays from top image marked by + showing 
robust cx43 expression. (B) (Top) Representative image of a fin microinjected with 
esco2-MM in one half and the other side uninjected (UN) reveal similar levels of 
cx43.  (Bottom left) Higher magnification of the esco2-MM injected side (MM) of the 
same fin (fin rays from top image marked by *) showing cx43 expression. (Bottom 
right) Higher magnification of the uninjected side (UN) of the same fin (fin rays from 
top image marked by + showing similar cx43 expression levels. Scale bar is 100 µm. 
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Figure 2.10: cx43 and cx43-dependent target genes are reduced following Esco2 
knockdown. The fold difference values from qRT-PCR are shown. A fold difference 
of 1 indicates no change with respect to standard MO treated fins. Three independent 
Esco2 knockdown (KD) samples were prepared. Each sample was tested in duplicate 
(trials 1-3) for cx43, sema3d, hapln1a, shh, spry4 and mps1, and compared to the 
internal reference gene. Circles represent the individual trials and solid circles 
represent the averages. 
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Figure 2.11: Upregulation of both cx43 mRNA and Cx43 protein in regenerating 
fins of the transgenic line treated for heat shock. (A) Expression of cx43 mRNA in 
transgenic hsp70:miR-133sp pd48-positive (Tg+HS+) and hsp70:miR-133sp pd48-
negative (Tg-HS+) fins by whole mount ISH. The Tg+HS+ fins show a higher 
expression of cx43 mRNA compared to Tg-HS+ fins. The brackets mark the zone of 
cx43 expression in each fin ray and the horizontal line represents the amputation 
plane. Scale bar is 50 µm. (B) Western blot reveals a 50% upregulation of Cx43 
protein levels in fin lysates of Tg+HS+ compared to Tg-HS+. Tubulin was used as a 
loading control. The bands marked were used for relative band intensity analysis 
using the gel analysis tool (ImageJ software). (C) Expression of esco2 mRNA in 
transgenic hsp70:miR-133sp pd48-positive (Tg+HS+) and hsp70:miR-133sp pd48-
negative (Tg-HS+) fins by whole mount ISH. Tg+HS+ and Tg-HS+ fins show similar 
expression level of esco2 mRNA. The brackets mark the zone of esco2 expression in 
each fin ray and the horizontal line represents the amputation plane. Scale bar is 50 
µm. (D) Western blot reveals the Esco2 protein expression is nearly similar (90%) in 
fin lysates of Tg+HS+ and Tg-HS+. Tubulin was used as a loading control. The 
single band marked was used for relative band intensity analysis using the gel 
analysis tool (ImageJ software). 
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Figure 2.12: Overexpression of cx43 rescues Esco2 knockdown phenotypes. (A) 
Figure depicting the timeline of fin amputation, morpholino injection and 
electroporation, heat shock, and data analysis. The 3 groups included in this 
experiment were Tg+HS- (transgenic hsp70:miR-133sp pd48-positive, heat shocked), 
Tg-HS+ (transgenic hsp70:miR-133sp pd48-negative, heat shocked) and Tg+HS- 
(transgenic hsp70:miR-133sp pd48-positive, not heat shocked). Briefly, fins from all 
three groups were amputated at 50% level and allowed to regenerate for 3 days. At 3 
dpa, morpholino was injected to one half of the regenerating fin tissue, immediately 
followed by electroporation on both sides. After an interval of 4 hours fish receiving 
heat shock were shifted to 37°C for 1 hour. Induction of the transgene expression 
upon heat shock was confirmed after 24 hours by screening for GFP-positive fins in 
the Tg+HS+ group. The control groups (Tg-HS+ and Tg+HS-) were negative for GFP 
expression. For ISH experiments, the fins were harvested at 1 dpe/4 dpa. For 
measurement of regenerate length and segment length fins were calcein stained at 4 
dpe/7 dpa. For each experiment at least 6-8 fish were used per trial and at least 3 
independent trials were performed (B) Graph reveals significant (*) rescue of esco2-
dependent segment length defects in heat shocked miR-133sp pd48 -positive Esco2 
knockdown fins (Tg+HS+) compared both to heat shocked transgene-negative (Tg-
HS+) and to miR-133sp pd48 -positive with no heat shock (Tg+HS-). Measurements 
from the injected side and the uninjected side of the same fin were used to calculate 
percent similarity and the average was calculated for each group. Note that a percent 
similarity of 100% indicates no difference between the knockdown side and the 
control sides of the fin. Student’s t-test was used for determining statistical 
significance where p < 0.05. Error bars represent standard error. (C) Graph reveals 
significant (*) rescue of esco2-dependent regenerate length defects in heat shocked 
miR-133sp pd48 -positive Esco2 knockdown fins (Tg+HS+) compared both to heat 
shocked transgene-negative (Tg-HS+) and to miR-133sp pd48 -positive in the absence 
of heat shock (Tg+HS-). 
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Figure 2.13: New model depicts the connection between Esco2 and Cx43 skeletal 
patterning pathway during fin regeneration. Proposed pathway for Esco2 
regulation of cx43 expression levels and genes downstream of cx43. Esco2 may have 
additional targets.  
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2.6 Table 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1: Quantitative RT-PCR confirms changes in gene expression 
a. The ΔCT value is determined by subtracting the average Keratin CT value from the 
average Gene CT value. The standard deviation of the difference is calculated from the 
standard deviations of the gene and Keratin values using the Comparative Method. 
b. The calculation of ΔΔCT involves subtraction by the ΔCT calibrator value. This is 
subtraction of an arbitrary constant, so the standard deviation of ΔΔCT is the same as the 
standard deviation of the ΔCT value. 
c. The range given for gene relative to MM is determined by evaluating the expression: 
2^ –ΔΔCT with ΔΔCT + s and ΔΔCT – s, where s = the standard deviation of the ΔΔCT 
value.   
 
 
 
 
Gene Average 
CT(esco2 
KD) 
Avera
ge CT 
(keratin) 
∆CT 
esco2 KD 
-keratina 
∆CT 
esco2 MM 
-keratina 
∆∆CT      
∆CT(MO
)- ∆CT 
(MM)
b 
Fold 
Difference 
relative to 
MM c 
cx43 23.31 + 
0.11 
17.14 
+ 0.15 
6.16 + 
0.19 
5.21 + 0.14 0.95 + 
0.24 
0.51 (0.43 -
0.61) 
sema3d 24.25 + 
0.15 
17.25 
+ 0.07 
7.0 + 0.16 6.05 + 0.12 0.94 + 
0.21 
0.52 (0.44 - 
0.6) 
hapln1a 24.43 + 
0.05 
18.09 
+ 0.04 
6.34 + 
0.07 
5.57 + 0.42 0.85 + 
0.42 
0.58 (0.43- 
0.78) 
mps1 22.27 + 
0.08 
17.72  
+ 0.08 
4.55 + 
0.12 
4.47 + 0.34 -0.08 + 
0.36 
0.94 (0.73 -
1.21) 
shh 22.7 + 
0.1 
19.51 
+ 0.05 
3.24 + 
0.11 
3.53 + 0.14 -0.28 + 
0.18 
1.21 (1.07-
1.38) 
spry4 23.3 + 
0.08 
19.35 
+ 0.1 
3.91 + 
0.13 
4.45 + 0.31 -0.54 + 
0.34 
1.45 (1.14- 
1.85) 
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CHAPTER 3 
 
 
Cohesin mediates Esco2-dependent transcriptional regulation in zebrafish 
regenerating fin model of Roberts Syndrome 
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3.1 Abstract  
        Robert syndrome (RBS) and Cornelia de Lange syndrome (CdLS) are human 
developmental disorders characterized by craniofacial deformities, limb malformation, 
and mental retardation. These birth defects are collectively termed cohesinopathies as 
both arise from mutations in cohesion pathway genes. The mechanism that underlies 
RBS, however, remains unknown. Previously, I used the clinically relevant CX43 to 
demonstrate a transcriptional role for Esco2. In this chapter, I show that morpholino-
mediated knockdown of Smc3 perturbs zebrafish bone and tissue regeneration, producing 
similar results to those previously reported for Esco2 knockdown. Additionally, Smc3 
knockdown also reduces cx43 expression. Importantly, Smc3-dependent bone and tissue 
regeneration defects are rescued by transgenic cx43 overexpression, providing evidence 
that Smc3 directly contributes to RBS-type phenotypes in the regenerating fin model 
produced by Esco2 knockdown. Moreover, chromatin immunoprecipitation (ChIP) assays 
revealed that Smc3 binds to a discrete region of the cx43 promoter, suggesting that Esco2 
exerts transcriptional regulation of cx43 through modification of Smc3 bound to the cx43 
promoter. These findings unify RBS and CdLS as transcription-based maladies.  
 
This work is currently under the revision process in Biology Open: Banerji, R, 
Iovine, M.K. and Skibbens, R.V, 2017. Cohesin mediates Esco2-dependent 
transcriptional regulation in zebrafish regenerating fin model of Roberts syndrome. 
Funding: Nemes Fellowship and Lehigh University Faculty Innovation Grant. 
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3.1 Introduction  
          Roberts syndrome (RBS) is a multi-spectrum developmental disorder characterized 
by severe skeletal deformities resulting in craniofacial abnormalities, long-bone growth 
defects and mental retardation (Van den Berg and Francke, 1993; Vega et al., 2005). 
Infants born with severe forms of RBS are often stillborn and even modest penetrance of 
RBS phenotypes lead to significantly decreased life expectancy (Schule et al., 2005). 
Cornelia de Lange Syndrome (CdLS) patients exhibit similar phenotypes to RBS patients 
that include severe long-bone growth defects, missing digits, craniofacial abnormalities, 
organ defects and severe mental retardation (Liu and Krantz, 2009; Mannini et al., 2010). 
Collectively, RBS and CdLS are termed cohesinopathies as they arise due to mutations in 
cohesion genes, most of which were originally identified for their role in sister chromatid 
tethering reactions (termed cohesion) (Vega et al., 2005; Schule et al., 2005; Gordillo et 
al., 2008; Krantz et al., 2004; Musio et al., 2006; Tonkin et al., 2004; Deardorff et al., 
2007;Deardorff et al., 2012a, Deardorff et al., 2012b). Cohesins are composed of two 
structural maintenance of chromosome (SMC) subunits, SMC1A and SMC3, and several 
non-SMC subunits that include RAD21 (Mcd1/Scc1), SA1, 2 (stromal antigen/Scc3/Irr1) 
and PDS5. At least a subset of cohesion subunits form rings that appear to topologically 
entrap DNA (Jeppsson et al., 2014; Dorsett, 2016; Marston, 2014).  
          RBS is an autosomal recessive disease that arises due to loss of function mutations 
in the ESCO2 gene that encodes an N-acetyltransferase (Ivanova and Ivanov, 2002; Vega 
et al., 2005). ESCO2/EFO2 (and ESCO1/EFO1 paralog) are the human orthologues of 
the ECO1/CTF7 first identified in budding yeast (Skibbens et al., 1999; Toth et al., 1999; 
Bellows et al., 2003; Hou and Zou, 2005). All ESCO/EFO family N-acetyltransferases 
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modifies the SMC3 cohesin subunit (Zhang et al., 2008; Unal et al., 2008; Rolef Ben-
Shahar et al., 2008). ESCO2 plays an essential role in sister chromatid cohesion during S 
phase and ensures proper chromosome segregation during mitosis. In contrast, CdLS 
arises due to autosomal dominant mutations in cohesin subunits (SMC1A, SMC3 and 
RAD21) and cohesin auxiliary factors (NIPBL and HDAC8) (Krantz et al., 2004; Tonkin 
et al., 2004; Schule et al., 2005; Musio et al., 2006; Deardorff et al., 2007;Deardorff et al., 
2012a, Deardorff et al., 2012b; Gordillo et al., 2008; Yuan et al., 2015). NIPBL/Scc2 and 
MAU2/Scc4 heterodimer complex are required for cohesin ring opening/closing reactions 
that loads cohesins onto DNA (Dorsett and Merkenschlager, 2013; Skibbens, 2016). 
  Extensive research provides fascinating evidence that cohesin functions beyond 
sister chromatid cohesion (trans-tethering that brings together two DNA molecules). 
Cohesins also participate in various cis- tethering events such as transcriptional 
regulation via looping and chromosome condensation (Dorsett and Merkenschlager, 
2013). Intriguingly, cohesins form both cis and trans- DNA tethers throughout the 
genome and throughout the cell cycle, a circumstance that has hampered efforts to 
understand the specific structures and functions, when mutated, which contribute to the 
molecular etiology of cohesinopathies. For instance, work from various model systems 
strongly suggest that CdLS arises through transcriptional deregulation that involves 
mostly cis-DNA tethers formed during G1 portion of the cell cycle. In contrast, a 
predominant view is that RBS arises through trans-tethering defects that result in mitotic 
failure and loss of progenitor stem cells through apoptosis (Monnich et al., 2011; Morita 
et al., 2012; Percival et al., 2015). More recent evidence, however, is consistent with an 
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emerging model that transcriptional deregulation may underlie RBS as well as CdLS 
(Banerji et al., 2016; Xu et al., 2013; Xu et al., 2014). 
          The zebrafish regenerating caudal fin is a valuable model system for studies related 
to skeletal morphogenesis (Iovine, 2007; Ton and Iovine, 2013). Advantages of the adult 
fin include its simple structure, accessibility, and its capacity for epimorphic 
regeneration. Furthermore, the regenerating fin eliminates any potentially confounding 
effects of embryonic lethality observed during development upon cohesin gene 
knockdown (Monnich et al., 2011; Morita et al., 2012). In the previous chapter (also 
published as Banerji et al., 2016), I report on a novel regenerating fin model of RBS and 
documented the role of esco2 in skeletal and tissue regrowth. Importantly, I revealed that 
Esco2 is critical for Connexin43 (cx43) expression. Cx43 comprises gap junctions which 
confer direct communication between cells through channels that allows small signaling 
molecules (<1000 Da) to pass (Goodenough et al., 1996). CX43 function is conserved 
among vertebrates, is the most abundant connexin in bone cells, and is important for 
skeletal development such that CX43 mutations lead to the skeletal disorder 
Oculodentodigital dysplasia (ODDD) in humans and mice (Paznekas et al., 2003; 
Flenniken et al., 2005; Jones et al., 1993). In zebrafish, mutations in cx43 cause short fin 
(sof b123), phenotypes that include reduced fin length, reduced bone segment length, and 
reduced cell proliferation (Iovine et al., 2005). Here, I provide evidence that Smc3 
knockdown recapitulates both Esco2 and Cx43 knockdown phenotypes (i.e. decreased 
bone segment and tissue regrowth). Critically, smc3 is required for cx43 expression. 
Moreover, I mapped Smc3 binding within the cx43 promoter, consistent with the model 
that Smc3 directly impacts cx43 expression. These findings provide new insight 
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regarding the underlying molecular mechanism of RBS, indicating that Esco2 activated 
Smc3 binds to clinically relevant skeletal regulatory genes. 
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3.3 Materials and methods 
Statement on the Ethical Treatment of Animals 
This work was performed strictly according to the recommendations in the Guide for the 
Care and Use of Laboratory Animals of the National Institutes of Health. Lehigh’s 
Institutional Animal Care and Use Committee (IACUC) approved the protocols 
performed in the manuscript (Protocol identification # 190, approved 05/19/16). Lehigh 
University’s Animal Welfare Assurance Number is A-3877-01. All experiments were 
performed to minimize pain and discomfort. 
 
Housing and Husbandry 
Zebrafish (Danio rerio) were housed in a re-circulating system built by Aquatic Habitats 
(now known as Pentair). The fish room has a 14:10 light: dark cycle with tightly 
regulated room temperature ranging from 27 to 29°C (Westerfield, 1993). Monitoring of 
the water quality is done automatically to maintain conductivity of 400–600 µs and pH in 
the range of 6.95–7.30. A biofilter is used to maintain nitrogen levels and a 10% water 
change occurs daily. Sequential filtration of recirculating water was carried out using pad 
filters, bag filters, and a carbon canister before circulating over ultraviolet lights for 
sterilization. Fish feeding schedule was as follows: fed three times daily, once with brine 
shrimp (hatched from INVE artemia cysts) and twice with flake food (Aquatox AX5) 
supplemented with 7.5% micropellets (Hikari), 7.5% Golden Pearl (300–500 micron, 
Brine Shrimp direct), and 5% Cyclo-Peeze (Argent). 
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Zebrafish Strains and fin amputations 
Both wild-type (C32) and Tg (hsp70: miR-133sppd48) (Yin et al., 2012) Danio rerio 
animals were used. Males and females from 6 months-1 year of age were included. All 
procedures involving caudal fin amputations, fin regeneration, and harvesting were done 
as previously described (Banerji et al., 2016). Briefly, 0.1% tricaine solution was used for 
fish anaesthetization and their caudal fin rays amputated at 50% level using a sterile razor 
blade. Regenerating fins were harvested at the required time points and fixed in 4% 
paraformaldehyde (PFA) overnight at 4°C. The fixed fins were dehydrated in methanol 
(100%) and stored at 20°C until further use. 
 
Morpholino-mediated gene knockdown in regenerating fins  
The morpholinos (MOs) used were all fluorescein-tagged and purchased from Gene 
Tools, LLC. The sequences for MOs are as follows: (MO1) smc3-ATG blocking MO: 5′- 
TGTACATGGCGGTTTATGC -3′, (MO2) smc3-splice blocking MO: 5′- 
GCGTGAGTCGCATCTTACCTGTTTA-3′, esco2 –MO and Standard Control MO (Std-
MO) from Banerji et al., 2016. MOs were reconstituted to a final concentration of 1 mM 
in sterile water. Microinjection and electroporation procedures were carried out as 
described in the previous studies (Banerji et al., 2016).  
 
Regenerate Length, segment length, and H3P analyses 
MO injected fins were calcein stained at 4 dpe/7 dpa and regenerate length and segment 
length was determined as described (Du et al., 2001; Banerji et al., 2016). For detection 
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of mitotic cells, histone-3-phosphate (H3P) assay was performed on fins harvested at 1 
dpe/4 dpa as described (Banerji et al., 2016).  
 
RNA extraction and RT-PCR analysis on regenerating fins 
RT-PCR analysis was performed on total mRNA extracted from 1 dpe/4 dpa harvested 
fins that were either injected with smc3 splice blocking MO (MO2) or Std-MO injected. 
Trizol reagent (Gibco) was used to extract mRNA from minimum of 8-10 fins. For 
making cDNA, 1 mg of total RNA was reverse transcribed with SuperScript III reverse 
transcriptase (Invitrogen) using oligo (dT) primers. Two pairs of primers were used for 
testing the splicing efficiency. The control primer pair (C1-C2) was designed to amplify a 
portion of the exon 1 of smc3 mRNA whereas the targeting primer pair (P1-P2) was 
designed to amplify the exon1 along with a portion of the intron1. The sequences of the 
control primers are as follows: C1 (forward primer) 5’- 
GACTGTTATGTCTTTTGCGTG-3’ and C2 (reverse primer) 5’ 
GCGGTTTATGCACAAAACACT-3’. The sequences of the targeting primers are as 
follows: P1 (forward primer) 5’-GGAGGAGGGTGTTTAATTCAGC-3’ and P2 (reverse 
Primer) 5’-GCTTCGAAAGCCTTGAATAATGAC-3’. 
 
RNA probe preparation for in situ hybridization on whole-mount /cryosectioned fin 
The cx43 template was made as described (Iovine et al., 2005). The smc3 template was 
generated using gene-specific primers (Forward primer 5’-
CAAACTGTGGTCGATCCCTTCAGC and reverse primer 5-
’TAATACGACTCACTATAGGGGCTTCTCTTCAATCTTCT-3’). The RNA 
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polymerase T7 (RT7) binding site is highlighted in bold for the reverse primer. 
Digoxigenin-labelled RNA probes were generated and whole mount/cryosection in situ 
hybridization was completed as previously described (Banerji et al., 2016).  
 
Transgenic overexpression of cx43  
Tg(hsp70:miR-133sp pd48) denoted as transgene-positive (Tg+) and their siblings 
denoted as transgene-negative (Tg-) were used in the heat shock experiment as previously 
described (Banerji et al., 2016). Knocking down miR-133 (which targets cx43 for 
degradation) via the ‘sponge’ transgene (three miR-133 binding sites) results in the 
increase of cx43 levels (Yin et al., 2012).  
 
Morpholino-mediated protein knockdown via electroporation in AB9 cells  
AB.9 (ATCC® CRL-2298™) is a primary fibroblast cell line originating from the 
zebrafish caudal fins. Once the cells were at 80- 90% confluency in 100 mm dishes (28°C 
with 5% CO2) knockdown procedure was completed (Bhadra et al., 2015). Briefly, the 
adherent cells were washed with 1X PBS and trypsinized in 0.05% Trypsin-EDTA 1X 
(Gibco) for 5 min at 28˚C. DMEM media supplemented with 15% heat inactivated FBS, 
antibiotics-antimycotics (Gibco) were added to inactivate the trypsin. The cells were 
collected by centrifugation at 750 rpm for 5 minutes. The pellet was re-suspended in 1-
5ml of HEPES buffer (115mM NaCl, 1.2mM CaCl2, 1.2mM MgCl2, 2.4mM K2PO4 and 
20mM HEPES with pH adjusted to 7.4) and put on ice. MOs were added to 400µl of re-
suspended cells in the cuvettes on ice and incubated for 5 minutes. The cells were 
electroporated at 170V for 6-7 ms using an electroporater (BioRad Gene Pulser X Cell). 
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Electroporated cells were added to 1ml of fresh media in 60mm culture dishes and 
incubated at 28˚C for 24 hours.  
 
Lysate preparation and immunoblotting 
For cell lysate preparation for western blots, AB9 cells were washed in cold PBS and 
cold lysis buffer (5mM Tris-HCl, 5mM EDTA, 5mM EGTA with pH 7.5) with 100X 
Halt-TM protease and phosphatase inhibitor cocktail (Thermo Scientific) and 0.6% SDS 
buffer. A sterile rubber cell scraper (Corning Incorporated, Costar) was used for scraping. 
A 5ml syringe (Beckton Dickinson) with an 18G needle was used to collect the lysate in a 
fresh tube and was heated at 100˚C for 3 min. A 26G needle (Beckton Dickinson) was 
used to pass the lysate through at least 3 times. The cell lysates were stored in small 
aliquots in -80˚C. These cell lysates were used to run western blot as described (Hoptak-
solga et al., 2008). Cx43, Esco2, Smc3 and Tubulin were detected using anti-Cx43 
(1:1000, Hoptak-Solga et al., 2008), anti-Esco2 (1:1000, Banerji et al., 2016), anti-Smc3 
(1:1000, Santa Cruz) and anti-α-Tubulin (1:1000, Sigma) respectively. The primary 
antibody step was followed by incubation in peroxidase-conjugated goat anti-rabbit IgG 
(1:10,000) for Cx43 and Esco2, peroxidase-conjugated rabbit anti-goat IgG (1:10,000) 
for Smc3 and peroxidase-conjugated goat anti-mouse IgG (1:10,000) for Tubulin. The 
ECL chemiluminescent reagent (SuperSignal West Femto Maximum Sentivity Substrate, 
Pierce Rockford, IL) and X-ray films were used for signal detection. For measurement of 
band intensities and the percent change calculation, the Image J software was used. 
Relative pixel densities of gel bands were measured using the gel analysis tool in ImageJ 
software as previously described (Bhadra and Iovine, 2015).  
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Immunofluorescence on AB9 cells 
Poly-L-lysine cover glasses were used for seeding the cells as previously described 
(Bhadra et al., 2015). Once cells were 70 -80% confluent, they were washed cold PBS 
and fixed with 4% PFA for 30 min at room temperature. This was followed by washes in 
PBS (3X for 5 minutes each), permeabilization with 0.2% triton for 10 minutes, followed 
by multiple washes in PBS. Blocking was done using 1% BSA for 1 hr at room 
temperature. The cover slips were incubated with the primary antibody (see above) 
overnight at 4˚C (in a covered chamber surrounded with damp Kim wipes). Cells were 
incubated with the secondary antibody for 1 hour at room temperature (protected from 
light). The secondary antibodies used were as follows: anti-rabbit Alexa 488 or 568 
(1:200, Invitrogen), anti-mouse Alexa 488 or 568 (1:200, Invitrogen). DAPI (1:1000, MP 
Biomedicals, LLC.) labels the nucleus. Cells were mounted with Vectashield (Vector 
Laboratories) and examined with Nikon Eclipse TE2000-U at 40X or 60X. 
 
Chromatin Immunoprecipitation (ChIP)  
ChIP protocol was performed on AB9 cells using the High-Sensitivity ChIP kit (Abcam, 
ab185913) according to manufacturer's instruction. The procedure for monolayer or 
adherent cells was followed with few modifications. Briefly, cells were grown to 80%-
90% confluence on 100 mm dishes (around 4-6 dishes per round of ChIP), trypsinized 
and centrifuged at 1000 rpm for 20 minutes. The pellet was washed with 10 mL of 1X 
PBS and again centrifuged at the same speed and time. For cross-linking, 9 ml DMEM 
medium-containing formaldehyde (final concentration of 1%) was added to the cells and 
incubated at room temperature for 10 minutes on a rocker. After 10 minutes 1.25 M 
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Glycine solution was added and centrifuged at 1000 rpm for 20 minutes followed by a 
washing step with 10 mL of ice cold 1X PBS. After another round of centrifugation, 
Lysis Buffer with protease inhibitor was used to re-suspend the cell pellet (200μL/1x106 
cells) and incubated on ice for 30 minutes with periodic vortexing. The solution was 
centrifuged at 3000 rpm for 20 minutes and the chromatin pellet re-suspended with the 
ChIP Buffer supplied in the kit (100 μl/1x106 cells). Chromatin was sheared using a tip 
sonicator (Branson sonfier cell disrupter 200) with a 2.4 mm tip diameter microprobe, 
(Qsonica P-3) set to 25% power output. Sonication was carried out in 3-4 pulses of 10-15 
seconds each, followed by 30-40 seconds rest on ice between each pulse. The sonicated 
chromatin was centrifuged at 12,000 rpm at 4°C for 10 minutes and stored at -20°C. A 
small amount of chromatin solution was used for DNA extraction in order to verify the 
size of the sheared DNA before starting the immunoprecipitation procedure (100-700 bp 
with a peak size of 300 bp). Antibody binding to assay wells and ChIP reactions was 
performed according to the manufactures instructions. Antibodies used were anti-IgG 
(kit) and anti-Smc3 (Santa Cruz) with a concentration of 0.8 µg/well for both antibodies. 
The sealed strip wells with the respective antibodies and Antibody Buffer (kit) were 
incubated for 90 mins at room temperature on an orbital shaker. ChIP reaction was set up 
according to the low abundance target criteria (details provided in the protocol booklet) 
overnight at 4°C on an orbital shaker. Next day the wells were washed with Wash buffer 
(kit) and DNA release buffer and cross-links were reversed (according to the manual). 
The released DNA was used in PCR or qRT-PCR reactions. 
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ChIP primer design and qPCR  
The zebrafish cx43 promoter sequence was obtained from the BAC clone (DKEY-
261A18). Overlapping 31 primer pairs were designed spanning the entire 6.7 kb region of 
the cx43 promoter (Table S1). For qRT-PCR analysis, the primers were designed using 
the Primer Quest tool software from IDT (Table 3.2). Three independent samples were 
prepared for ChIP, and qRT-PCR reactions were performed in duplicate. ChIP DNA for 
non-immune IgG served as the negative control. The templates were a 1:10 dilution 
following ChIP using either IgG or Smc3 antibodies. PCR reactions were set up using 
SYBR green kit (Qiagen). Analyses of the amplified samples were done using Rotor-
Gene 6000 series software (Corbette Research) and the average cycle number (CT) 
determined for each amplicon. For fold enrichment calculation the smc3 CT values were 
normalized relative to IgG control values and were represented as delta CT (ΔCT). The 
fold enrichment was determined using the ΔΔCT method (2-ΔΔ CT). Statistical significance 
was determined by one-way ANOVA test (P<0.001) using the MINITAB 17 software. 
 
Statistical analysis 
All graphs and error bars were generated using the Microsoft excel (2013) software. For 
statistical significance calculation, two-tailed unpaired t-test was performed using 
Graphpad software (La Jolla California USA, www.graphpad.com). Statistical 
significance was also determined by one-way ANOVA test (P<0.001) using the 
MINITAB 17 software. 
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3.4 Results 
Expression of smc3 in the regenerating fin  
 Esco2 is a critical regulator of fin skeletal and tissue regeneration that is required 
for expression of the developmental signaling factor cx43 (Banerji et al., 2016). While 
Esco2 is essential for modifying the cohesin subunit Smc3 to produce sister chromatid 
tethering and high fidelity chromosome segregation, a role for Smc3 in mediating Esco2-
dependent RBS-like skeletal and tissue defects remains unknown. To address this gap in 
knowledge I evaluated smc3 expression and function during fin regeneration. First, I 
completed in situ hybridization to monitor the temporal expression of smc3 mRNA in 1, 
3, 5, 8 and 14 days post amputated (dpa) fins. The results reveal that smc3 mRNA is 
strongly expressed 3 dpa, similar to esco2 expression (Figure 3.1A). smc3 expression 
decreased by 5 dpa fins and was negligible by 14 dpa (Figure 3.1A). Thus, the smc3 
expression mirrors that of esco2 - both of which peak in expression at 3 dpa when 
regeneration is at its peak (Banerji et al., 2016; Lee et al., 2005; Hoptak-Solga et al., 
2008).  
            Expression of esco2 mRNA is localized to the highly proliferative blastemal 
compartment of the fin (Banerji et al., 2016). To test whether smc3 expression is 
localized similarly to the blastema, I performed in situ hybridization on 3 dpa 
cryosectioned fins. The results reveal that the expression of smc3 correlate with esco2 
localization (Figure 3.1B), but that smc3 also extends to the epidermis, mesenchyme and 
skeletal precursor cells (Figure 3.1B, left panel). No staining was detected in 3 dpa 
cryosectioned fin in the absence of the smc3 probe (Figure 3.1B, right panel). In 
combination, these studies reveal that smc3 expression both temporally and spatially 
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coincides with that of esco2 expression, consistent with a requirement during the early 
stage of regeneration specifically in the proliferative blastemal compartment of the 
regenerating fin.  
 
Knockdown of Smc3 results in reduced regenerate length, segment length and cell 
proliferation  
             In my first publication I have reported that Esco2 is essential for regenerate 
length, segment length and cell proliferation in the regenerating fins (Banerji et al., 
2016). To provide evidence that cohesins may mediate these Esco2-dependent effects, I 
designed two independent non-overlapping MOs that target Smc3: one targeting smc3 
ATG (MO1) and the second targeting the first splice site junction (exon1-intron1; e1i1) 
of smc3 gene (MO2) (Figure 3.2A). Thus, MO1 blocks translation of Smc3 whereas MO2 
alters the smc3 pre-mRNA proper splicing. All results were compared to a standard 
negative control MO (Std-MO) as previously described (Banerji et al., 2016; Bhadra et 
al., 2015).   
           I first validated the efficiency of the two smc3 MOs. MO1 efficiency was tested by 
monitoring Smc3 protein levels in AB9 cells transfected with either MO1or Std-MO 
(Bhadra et al., 2015). AB9 cells are primary fibroblasts derived from regenerating caudal 
fins of the adult zebrafish (Bhadra et al., 2015). The results reveal that the Smc3 protein 
levels were significantly reduced (60%) in the Smc3 knockdown lysates compared to the 
control lysates (Figure 3.2B). To confirm the effectiveness of splice blocking MO2, I 
performed RT-PCR in 4 dpa regenerating fins. RT-PCR results reveal that intron1 was 
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retrieved only when fins were injected with MO2 and not when injected with Std-MO 
(Figure 3.2C).  
          Using both MOs I carried out microinjection and electroporation as previously 
described (Govindan et al., 2016; Banerji et al., 2016) (Figure 3.2D). All MOs are tagged 
with fluorescein, allowing us to validate cellular uptake microscopically 1 day post 
electroporation (dpe) or 4 dpa. Only MO-positive fins were selected for further 
experiments. For measurement of regenerate length and segment length, Smc3 
knockdown/Std-MO fins were calcein stained at 4 dpe/7 dpa and measured. To reduce the 
effect of fin-to-fin variation, I utilized the percent similarity method in which 100% 
indicates no difference between injected and non-injected sides of the same fin, whereas a 
value less than 100% indicates differences between the injected and non-injected sides of 
the same fin (Govindan et al., 2016; Bhadra and Iovine, 2015; Banerji et al., 2016). 
Quantification of regenerate length was based on the distance from the plane of 
amputation to the distal end of the 3rd fin ray. Quantification of bone segment length was 
based on measurements obtained from the first segment distal to the amputation plane of 
the 3rd fin ray. The Std-MO injected fins showed a high percent similarity to the 
uninjected side, indicating that the control MO had no effect on regenerate and bone 
segment length as expected. In contrast, both MO1 and MO2 showed low percentage of 
similarities, indicating significant differences between the injected and non-injected 
sides. Thus Smc3 is critical for both regenerate length and segment length similar to 
Esco2 (Figure 3.3A-D).  
 Esco2 knockdown also results in reduced cell proliferation (Banerji et al., 2016). 
Thus, I next addressed whether the effect of Smc3 knockdown on both regenerate length 
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and segment length was based on altered cell proliferation rates. To test this, I quantified 
the number of mitotic cells by staining for Histone-3 phosphate (H3P) on 1 dpe Smc3 
knockdown (MO1 and MO2) and Std-MO injected fins. The results reveal significant 
reduction in H3P-positive cells in Smc3 knockdown fins compared to the control fins 
(Figure 3.3E, F). Thus, Smc3-dependent phenotypes are similar to both Esco2 and Cx43-
dependent phenotypes previously reported (i.e. reduced regenerate length, segment length 
and cell proliferation) (Banerji et al., 2016; Iovine et al., 2005). Having validated Smc3 
knockdown phenotypes using two non-overlapping MOs, all subsequent experiments 
were performed using a single targeting MO (MO1). 
 
smc3 and esco2 function together during skeletal regeneration 
 esco2 is critical for cx43 expression, although the basis for this regulation remains 
unknown (Banerji et al., 2016). Thus, it became important to determine if Smc3 
knockdown also influences cx43 expression. I performed whole mount in situ 
hybridization with cx43 probe on Smc3 knockdown fins. Half of the fin was injected with 
MO1 or Std-MO and the other half was kept uninjected as an internal control. 
Remarkably, the Smc3 knockdown side exhibited significantly reduced expression of 
cx43 compared to the uninjected side (Figure 3.4A). In contrast, the Std-MO injected side 
showed no difference in cx43 expression compared to the uninjected side (Figure 3.4B). 
          To determine the genetic relationship between smc3 and, I tested for rescue of 
smc3-MO phenotypes by over expressing cx43 (Banerji et al., 2016). For this purpose, I 
used the transgenic line, Tg(hsp70:miR-133sppd48) that indirectly over express cx43 in 
both regenerating heart and fins (Yin et al., 2012; Banerji et al., 2016). The three groups 
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of fish for this experiment were as follows: (1) transgene positive and heat shocked 
(Tg+HS+), (2) transgene negative and heat shocked (Tg-HS+) and (3) transgene positive 
but not heat shocked (Tg+HS-) (Figure 3.5A). Importantly, three independent heat shock 
trials revealed that both regenerate length and bone segment length defects otherwise 
exhibited in Smc3 knockdown were significantly rescued in the Tg+HS+ group (Figure 
3.5B). This rescue was specific to transgene activation and was not induced by heat shock 
alone or in combination with any other group. These findings support an exciting model 
that Smc3 functions upstream to regulate cx43 gene expression, similar to Esco2. 
 
AB9 cells are suitable for testing the smc3/esco2-cx43 skeletal pathway 
 What is the basis through which both Esco2 and Smc3 regulate cx43 expression? 
To address this issue, I switched to AB9 fibroblast cell line, that are less complex than 
regenerating fish fin tissue and previously reported to express Cx43 (Bhadra et al., 2015). 
I first tested whether AB9 cells also express Esco2 and Smc3. AB9 cells grown on a 
coverslip were fixed and processed for immunofluorescence. The results show that anti-
Esco2 antibody and anti-Smc3 antibody co-localize and overlap with the DAPI-stained 
nuclei (Figure 3.6A). I next tested whether either esco2- or smc3- similarly regulate Cx43 
protein levels as occurs in regenerating fins. Cx43 protein levels were monitored by 
Western blot in AB9 cells knocked down for either esco2 MO or smc3 MO. The results 
show that Esco2 or Smc3 proteins were each reduced using their respective knockdown 
morpholinos (Figure 3.6B). Critically, Cx43 protein levels also were reduced following 
either knockdown (Figure 6B). Therefore thes AB9 system recapitulates the effect of 
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Esco2 and Smc3 knockdown in reducing Cx43 expression levels, similar to results 
obtained in regenerating fins (Banerji et al., 2016). 
 
Smc3 directly binds to a specific region of the cx43 promoter  
          It is well established that cohesins bind directly and stabilize DNA-tethering 
structures required for efficient gene expression (Dorsett, 2016; Merkenschlager and 
Nora, 2016; Jeppsson et al., 2014). Thus, I hypothesized that Smc3, as a part of the 
cohesin complex, directly binds to a segment of the cx43 promoter. The cx43 promoter is 
approximately 6.7 kb in length, adjacent to an additional connexin gene (cx32.2) that 
resides upstream of the cx43 coding sequence (Chatterjee et al., 2005; Figure 3.7A). I 
assayed Smc3 binding to the cx43 promoter by performing Chromatin 
Immunoprecipitation (ChIP) on AB9 cells. I first optimized the ChIP procedure using 
Smc3 as the target antibody and IgG as the negative control. Since this is the first time 
that protein binding to the putative cx43 promoter is investigated, I performed qualitative 
PCR analysis. I designed 31 primers pairs that, in overlapping fashion, span the entire 6.7 
kb promoter (Table 3.1). Positive binding was observed for primers 2-6 (800bp), primer 
11 (250bp) and primers 18-28 (1.5kb). In contrast, the negative control (IgG) exhibited 
little to no binding throughout the promoter length (Figure 3.7A).  
          To investigate in detail the specific regions of the cx43 promoter to which Smc3 
binds, I next performed qRT-PCR. I designed 5 primer pairs that spanned the Smc3 
positive binding regions obtained from the qualitative PCR analysis (p2- p6) and 2 primer 
pairs as negative controls that fall within zones devoid of Smc3 binding (p1 and p7). The 
results reveal significant binding of Smc3 specifically within one region (p2) of the cx43 
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promoter (Figure 3.7B). Binding was also observed at p3-p6, but at levels that did not rise 
to statistically significant levels. The negative controls (p1 and p7) showed negligible 
binding. These ChIP results provide strong evidence that Smc3 binds directly to the cx43 
promoter.      
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3.5 Discussion 
         Esco2 mutations are the only known etiologic agent for RBS. Previously, I 
established Esco2 knockdown in regenerating fin as a powerful system from which to 
elucidate the molecular basis of RBS. One major revelation is that Smc3 functions in a 
similar manner as Esco2 during fin regeneration. First, smc3 mRNA expression coincides 
with esco2 expression, specifically in the proliferative blastemal compartment of the 
regenerating fin. Second, morpholino-mediated Smc3 knockdown revealed that Smc3-
dependent phenotypes i.e. reduced regenerate length and segment length and decreased 
cell proliferation, recapitulate the esco2/cx43-dependent phenotypes. Third, I see a 
reduction in the cx43 expression levels in Smc3 knockdown fins. Finally, cx43 
overexpression rescues Smc3-dependent phenotypes to a similar degree as Esco2-
dependent phenotypes. In combination with my previous findings (Banerji et al., 2016), 
these results provide strong evidence that Esco2, Smc3, and Cx43 function in a common 
pathway and that RBS is a transcriptional malady similar to CdLS.  
 A popular model is that Esco2 deficiency results in mitotic failure and progenitor 
cell death through apoptosis. A second revelation is that, a subset of RBS-type 
phenotypes may instead arise directly from defects in cohesin (Smc3) binding to the 
promoter of clinically relevant development genes. As proof of concept, the ChIP 
experiments demonstrate that Smc3 physically binds to the cx43 promoter and is 
required, along with Esco2, for efficient cx43 expression. Cx43 represents a valuable and 
informative target given that mutation in human CX43 results in ODDD, and that CdLS 
models similarly report aberrant expression of CX43 (Monnich et al., 2011; Kawauchi et 
al., 2009). These results, combined with the established role for Esco2 in Smc3-
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acetylation, provide compelling support for a model in which Esco2 and Smc3 act on the 
promoters of skeletal genes (i.e. cx43) to regulate transcription and thereby mediate 
proper skeletal development and morphogenesis (Figure 3.8).  
          Extensive research has been carried out to understand the structure of the cohesin 
complex and auxiliary factors, and their role(s) in mediating various DNA tethering 
events, with the intention of elucidating molecular mechanisms underlying 
cohesinopathies. Surprisingly, while both CdLS and RBS are grouped under a similar 
disease category, the etiologies of these sister maladies are considered different. 
Transcriptional deregulation is considered to be the primary mechanism underlying CdLS 
(Krantz et al., 2004; Tonkin et al., 2004; Gillis et al., 2004; Musio et al., 2006; Deardorff 
et al., 2007;Deardorff et al., 2012a, Deardorff et al., 2012b; Zhang et al., 2009). For 
example, defects in cis-DNA tethering events result in severe to mild phenotypes 
observed in CdLS. Cohesin subunits (SMC1A and SMC3) and NIPBL interact with 
Mediator complexes along with RNA polymerase II that bring long-distance enhancers to 
close proximity of the promoter of transcriptionally active genes via a cis-mediated DNA 
looping event (Kagey et al., 2010). The molecular mechanism underlying RBS is thought 
to occur through trans-tethering mitotic defects. It is true that mitotic failure and modest 
levels of apoptotic cells are often accompanied in mouse and zebrafish embryo studies of 
RBS. The current findings do not rule out the possibility that these can promote 
developmental defects (Monnich et al., 2011; Horsfield et al., 2012; Mehta et al., 2013; 
Whelan et al., 2012). However, the findings that RBS-type phenotypes can occur in the 
absence of apoptosis greatly diminishes these models. Instead, the data suggests a unified 
mechanism for both RBS and CdLS through transcriptional deregulation.  
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 Why do RBS cells often exhibit cohesion defects (Vega et al., 2005; Schule et al., 
2005)? Why do CdLS cells appear devoid of elevated levels of mitotic failure and 
apoptosis? I suggest contributions of gene dosage. For instance, an elegant study 
performed in yeast revealed differential dosage effects on a subset of cohesin related 
functions (Heidinger-Pauli et al., 2010). In humans, CdLS arises due to heterozygous 
dominant mutations in cohesion pathway genes. Thus, one functional copy of the gene 
may be sufficient to support cohesion but may not be sufficient to prevent changes in 
gene transcription. In contrast, RBS arises due to homozygous recessive mutations. 
Therefore, both copies of the ESCO2 gene are defective, which blocks all cohesion 
pathway function such that mitotic defects appear more prevalent. My studies 
demonstrating that Esco2 and Smc3 function together to regulate cx43 expression provide 
compelling evidence for a more unified model linking the underlying mechanisms of 
CdLS and RBS cohesinopathies. 
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3.6 Figures 
 
                                 
 
 
Figure 3.1: Expression of smc3 in whole mount and cryosectioned regenerating fins. 
(A) Expression of smc3 by whole mount in situ hybridization at various time points (1, 3, 
5, 8 and 14 days post amputation; dpa) (n=6 per timepoint). A solid line except in 8 dpa 
and 14 dpa regenerating fin indicates the amputation plane, unless it is out of the field of 
view. (B) In situ hybridization on 3 dpa longitudinal cryosectioned fin showing the 
tissue-specific localization of smc3 mRNA. The expression is observed in most 
compartments of the regenerating fin, being localized strongly at the blastemal 
compartment (b) with moderate expression in epidermis (e), mesenchyme (m) and 
skeletal precursor cells (*). The no probe control (3 dpa cryosectioned fin, right panel) 
shows no expression of smc3. Three independent trials were performed with different fin 
sections from 3 different fins. Scale bar is 50 µm (shown in 3 dpa panel) for all panels. 
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Figure 3.2:Validating the efficiency of smc3 morpholinos. (A) Schematic 
representation of the zebrafish smc3 pre-mRNA with exons (e) represented with grey 
boxes and the regions between the exons are the introns (i). The position of MO1 (ATG 
blocker) at the start codon of the smc3 gene is indicated by a blue bar (indicated on e1 
with a vertical line). MO2 is positioned at the first exon and intron junction of the splice 
donor site (e1i1). The positions of the control primer pairs (C1-C2) are indicated with 
blue arrows whereas the position of the target primer pairs (P1-P2) is indicated with red 
arrows. (B) Western blots confirming Smc3 protein reduction (60%) in MO1 injected 
AB9 cell lysate (lane 2) compared to the Std-MO injected lysate (lane 1). Tubulin was 
used as a loading control. Similar findings were observed in each of three trials (n=10 
fins per trial). (C) Results of RT-PCR analysis using CI-C2 and P1-P2 primer pairs for 
verifying the efficiency of MO2. The templates for both these primer pairs are numbered 
from 1 to 4 as follows: (1) genomic DNA extracted from regenerating fins, (2) cDNA 
from fins injected with Std-MO, (3) cDNA from fins injected with MO2 and (4) no 
template control (NTC). I used 3 fins to generate genomic DNA and 10 fins to generate 
cDNA. The C1-C2 primer pair amplified an expected 210 bp product. In contrast, the P1-
P2 pair amplified a 729 bp product in lane 3 (marked with *) due to the inclusion of 
intron1 (as predicted for MO2 injected sample) compared to lane 2 which did not amplify 
any product (as expected for Std-MO injected sample). (D) Schematic outline of 
knockdown experiments. Fins are amputated (50% level) and permitted to regenerate for 
3 days. At 3 dpa, either smc3 MOs (MO1 and MO2) or Std-MO (Standard control 
morpholino) was microinjected to one half of the regenerating fin keeping other half 
uninjected. This was immediately followed by electroporation on both injected and 
uninjected sides of the fin. The next day i.e.1 day post electroporation (dpe) or 4 dpa, the 
injected part of the fins were evaluated for MO uptake using a fluorescence microscope. 
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Only those fish that showed a strong signal of the fluorescein –tagged MO were used for 
further experiments. For experiments such as in situ hybridization (ISH), histone-3-
phosphate (H3P) and RNA extraction for RT-PCR, the fins were harvested at 1 dpe or 4 
dpa. Note that for RNA extraction, all fin rays across the fin were injected with MO and 
electroporated before harvesting. For regenerate length and segment length measurement 
and analysis, fins were allowed to regenerate for longer period and were calcein stained 
at 4 dpe or 7 dpa. For each experiment n=8 per trial and at least 3 independent trials were 
performed. 
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Figure 3.3: Morpholino mediated Smc3 knockdown results in regenerate length, 
segment length and cell proliferation reduction. (A) Representative images of 
uninjected (UN), smc3 MO injected (MO1) and Std-MO injected fins. Total regenerate 
length was calculated by measuring the distance between the amputation plane (indicated 
by a solid black line) to the distal end of the 3rd fin ray (purple arrows indicates the length 
measured). (B) Graph shows the significant reduction (indicated by *) of regenerate 
length in Smc3 knockdown fins (for both MO1 and MO2) compared to the Std-MO 
injected fins using the percent similarity method. (C) Representative images of calcein 
stained fins of uninjected (UN), smc3 MO injected (MO1) and Std-MO injected fins. 
Segment length was calculated by measuring the distance between first two joints in the 
3rd fin ray (purple arrows indicates the length measured). (D) Graph shows that 
significant reduction (indicated by *) of segment length in Smc3 knockdown (for both 
MO1 and MO2) compared to Std-MO injected fins using the percent similarity method. 
(E) Representative images of H3P-positive cells in uninjected (UN), smc3 MO injected 
(MO1) and Std-MO injected fins. Measurements were taken from the distal most 250μm 
of the 3rd ray. White bracket marks the defined area and n represents the number of H3P-
positive cells in that area. (F) Graph shows the significant reduction (indicated by *) in 
the number of H3P-positive cells in Smc3 knockdown (for both MO1 and MO2) 
compared to Std-MO injected fins using the percent similarity method. For each 
experiment n=8 fins per trial and 3 independent trials were performed. For statistical 
significance, two tailed unpaired student's t-test was used where P<0.05. Mean+ s.e.m. is 
represented by error bars. Scale bar is 50 µm for all panels. 
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Figure 3.4: smc3 regulates the expression of cx43 in regenerating fins. (A) 
Representative image of a fin with Smc3 knockdown side (smc3-MO) showing decreased 
cx43 staining compared to the uninjected side (UN). Higher magnification of the Smc3 
knockdown side of the same fin shows reduced levels of cx43 expression compared to the 
uninjected side (UN), which shows normal cx43 levels. (B) Representative image of Std-
MO injected fin revealing similar cx43 levels in both injected and uninjected side (UN). 
Higher magnification of the same fin shows normal and similar levels of cx43 expression 
in both injected and uninjected sides (UN). For this experiment n=6 fins per trial and 3 
independent trials were performed. A solid line indicates the amputation plane and scale 
bar is 100 µm and 50 µm.	
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Figure 3.5: Over expression of cx43 rescues smc3-dependent skeletal phenotypes.  
(A) Experimental timeline providing details of the fin amputation, MO 
injection/electroporation, heat shock and data analysis process. Fin amputation (50% 
level) was performed on transgenic hsp70:miR-133sppd48 fish (Tg+) and their siblings 
(Tg-). At 3 dpa, smc3 MO was injected in one half of the fin keeping the other half 
uninjected. This step was immediately followed by electroporating both sides of the fin. 
After a period of 4 hours, the heat shock process began. At this point there were total 3 
groups of fish: (1) Tg+HS+ is the transgenic-positive fish that were heat shocked at 37°C 
for 1 hour, (2) Tg+HS- is the transgenic-positive fish but were not heat shocked and (3) 
Tg-HS+ were the siblings (transgenic-negative) that were similarly heat shocked as 
Tg+HS+. At 4 dpa or 1 dpe the Tg+HS+ fins were screened for positive GFP expression, 
which indicated transgene induction. The control groups (Tg+HS- and Tg-HS+) were 
GFP-negative indicating absence of transgene induction. For regenerate length and 
segment length measurement and data analysis, fins were calcein stained at 7 dpa or 4 
dpe. (B) The graph reveals significant (indicated by *) rescue of smc3-dependent 
regenerate and segment length defects in Tg+HS- Smc3 knockdown fins compared to the 
control groups (Tg-HS+ and Tg+HS-). For each experiment n=8 fins per trial and 3 
independent trials were performed. For statistical significance, two tailed unpaired 
student's t-test was used where P<0.05. Mean+ s.e.m. is represented by error bars. Scale 
bar is 50 µm for all panels. 
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Figure 3.6: AB9 cells as a system to evaluate cohesin-binding at the cx43 promoter.  
(A) Expression of Esco2 and Smc3 are detected in AB9 cells by immunofluorescence. 
The anti-Esco2 antibody and anti-Smc3 antibody stains the nuclei of the cells (DAPI, 
blue), indicated with arrows. For each protein, 3 independent trials were performed. Scale 
bar is 10 µm (B) Western blot analysis detects the Esco2 in Std-MO electroporated 
control cell lysates (Lane1: Control) at a predicted size of 68 kDa. A reduction in Esco2 
protein levels in MO1-electroporated Esco2 knockdown cell lysate (lane 2: Esco2 KD) 
was observed when compared to the control sample (lane 1: Control). The results with 
anti-Cx43 antibody reveals reduced Cx43 protein levels (detected at 43 kDa as predicted) 
in Esco2 KD compared to control. Western blot analysis detects Smc3 in Std-MO 
electroporated control cell lysates (lane1: Control) at a predicted size of 142 kDa. A 
reduction in Smc3 protein levels in MO1-electroporated Smc3 knockdown cell lysate 
(lane 2: Smc3 KD) was observed when compared to the control sample (lane 1: Control). 
The results with anti-Cx43 antibody reveals reduced Cx43 protein levels (detected at 43 
kDa as predicted) in Smc3 KD compared to control. Tubulin detected at 50 kDa was used 
as the loading control for both blots. Image J software was used for analysis of relative 
band intensity from data of 3 independent trials. 
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Figure 3.7: Smc3 binds at a specific location of the cx43 promoter (A) Schematic 
representation of the zebrafish cx43 promoter. It is approximately 6.7 kb in length, 
adjacent to an additional connexin gene (cx32.2). The horizontal bars indicate the binding 
regions of Smc3 inferred from qualitative PCR results. The positions of the seven qRT-
PCR primer pairs (p1-p6) are indicated on the promoter region. The two primer pairs (p1 
and p7) are the negative controls, since they lie at a region not predicted from previous 
PCR results. (B) The graph represents the fold enrichment of Smc3 binding (normalized 
to IgG) at different regions of the cx43 promoter. Significant enrichment was observed at 
p2 location of the promoter suggesting positive binding of Smc3 at the p2 region. 
Statistical significance was determined by one-way ANOVA test (P<0.001) and indicated 
with *. The mean+ s.e.m. is represented by error bars for 3 independent trials. 
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Figure 3.8: Esco2-dependent cis-DNA looping model underlying the etiology of RBS. 
(A) Schematic representation of the cohesin ring complex. It is composed of two 
structural maintenance of chromosome (SMC) subunits (SMC1A and SMC3) and three 
non-SMC subunits (RAD21, SA1, 2 and PDS5). The cohesin auxiliary factor, NIPBL- 
MAU2 heterodimer complex helps in cohesin ring opening/closing reactions that loads 
cohesins onto DNA. Another auxiliary factor, ESCO2 is a member of the ESCO family of 
N-acetyltransferases that acetylates the SMC3 cohesin subunit. (B) A model depicting the 
Esco2-dependent cis-DNA tethering mechanism underlying RBS in which the 
acetyltransferace Esco2 activates its target, Smc3 (denoted by Ac) that binds the cx43 
promoter, thus activating cx43 transcription. This process is believed to occur through a 
cis-DNA looping mechanism that connects the enhancer (E) and promoter (P) of the cx43 
gene. 
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3.5 Tables 
Table 3.1: PCR Primer sequences 
 
 
Name Primer sequence (5'-->3") PCR product 
Fp1 5'- AAA GGG TCA CGA AAC ACC -3' Negative Rp1 5'- TCA AAG ATG TCA CAT TTT ACC G -3' 
Fp2 5'- GGG TTG AGA CTA GAT GTC TGT -3' Positive Rp2 5'- GTT AAA TGT CTG TTG AAG GAG C -3' 
Fp3 5'- CCA CTT GAG TAT TAG ACT GTT TG -3' Positive Rp3 5'- TGT CAC TTT ATT TTG ATG GTC GG -3' 
Fp4 5'- GGC ATG TAG ATG CAA TGT AAC T -3' Positive Rp4 5'- GGA ACT AGA GGA GTA GTC TTG G -3' 
Fp5 5'- GCT TAT TCA ATC CAA GAC TAC TC -3' Positive Rp5 5'- ATG AAT GAG ATC AAA AAA GTA TGC -3 
Fp6 5'- GCA CGT AAA CTG TAA ACT TGC A -3' Positive Rp6 5'- GTC GAC AAG TTA AAA CCA GCC -3' 
Fp7 5'- GCT GAA ATC AGC CTA GGC -3' Negative Rp7 5'- GTT GGC TGC TTT TAG TTG G -3' 
Fp8 5'- GGC TGG TCA ACC AAC TAA A -3' Negative Rp8 5'- CCA ATG AAA AGG TGT GAA GC -3' 
Fp9 5'- GGT TGC TTT TTG TGC TTC ACA C -3' Negative Rp9 5'- ACA GCA CTA CCT ACT GCG -3' 
Fp10 5'- GCT AAA GTC ACA CTA GGG G -3' Negative Rp10 5'- CCA TCT CTG GGA AAC ATC C -3' 
Fp11 5'- CGT AGT GTA TGA GTG TGT GT -3' Positive Rp11 5'- ATG CAT ATG ACT GCT ATG GC -3' 
Fp12 5'- CCT TTT TCG ATG GGT TAT TTT CAC -3' Negative Rp12 5'- AAT ATT TTG CAA AAC AAC GAA CC -3' 
Fp13 5'- CCC ATA ACT CTG TGG TTC GTT -3' Negative Rp13 5'- CTT GTA GAG ACA GGA GTT CGG -3' 
Fp14 5'- GCA CTC GCT AAA CCG AA -3' Negative Rp14 5'- CGC AGG TAT TAT TTG AGT AGG C -3' 
Fp15 5'- CCG ACA GAA AGA AAC ACA CA -3' Negative Rp15 5'- CTT TCA TAA AAG GGG TTG ATC C -3' 
Fp16 5'- GGC TAG TAA TTG ACT TTT CAA GT -3' Negative Rp16 5'- AAA ACA AGT TGT AAC CTA TAG GC -3' 
Fp17 5'- CCA TTG TAG CCT ATA GGT TAC AA -3' Negative Rp17 5'- GGG TTT CCT CCA CAA TCC -3' 
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Fp18 5'- CCG AAT GTC TTT GGA TTG TG -3' Positive Rp18 5'- CCT TGT AGC CTA AAC TCG C -3' 
Fp19 5'- GGA TCA AGT GAG CGA GTT TA -3' Positive Rp19 5'- CTG GAA AGA AGT AAA GAG TGG -3' 
Fp20 5'- GGC TCT CCA CTC TTT ACT TC -3' Positive Rp20 5'- CAA ATA TGA ATC ATA TCA TGG CG -3' 
Fp21 5'- CGC CAT GAT ATG ATT CAT ATT TG -3' Positive Rp21 5'- AAT TTG TGA CTT CTA TTG AGG C -3' 
Fp22 5'- GGA ATA ACT TTT TGT TTT TGG GAG -3' Positive Rp22 5'- AGA ATT GCA GGT TAA AGT TTG C -3' 
Fp23 5'- CCT TCA TTT CAT GTA ACT CTG C -3' Positive Rp23 5'- ATA ATT GGA CAT GTT TGT GTC C -3' 
Fp24 5'- GGC AAT ATT AAA ATT CCA TCA CTT -3' Positive Rp24 5'- GGA ACC TAG CAT GAC ATA TAC G -3' 
Fp25 5'- CCA CGC AAG ACA AAG AAA TTA A -3' Positive Rp25 5'- GCA TAA CAC TAT TGA GGT GG -3' 
Fp26 5'- CCC TAA CCT TAC CCG TAT TC -3' Positive Rp26 5'- AGA AAA CAA GCA CAA TGC G -3' 
Fp27 5'- CCC ACT TAT TGT CTA AAC AAG AAT -3' Positive Rp27 5'- GCA TGG AAA GTC AAA TAT CAT AAG G -3' 
Fp28 5'- GGC AGT TCT TTA GAA CTT CTT AAA -3' Positive Rp28 5'- CAG CAA GTG AGT CAT CAT CC -3' 
Fp29 5'- GCT TGG CAA TGT TTT TTA ATG GT -3' Negative Rp29 5'- TGA AAA TAA TCA TGA AAG CTG ACC -3' 
Fp30 5'- CCT GAG GTC AGC TTT CAT GAT -3' Negative Rp30 5'- AAC AGT CCA TCA CTT TTA CTG C -3' 
Fp31 5'- GCA TGA ACT TGA AGG GGA A -3' Negative Rp31 5'- GAG TTC TAG CTG AAA ATA GAA AGC -3' 
Forward primer-fp and reverse primer-rp. Positive indicates the presence of a 
amplified PCR product for that primer pair and negative indicates no PCR product 
for that primer pair. 
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Table 3.2: PCR Primer sequences for ChIP- qRT PCR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name         Primer sequence (5'-->3") 
p1 fp- 5’-TGTGTCCCACATTGCCAAA-3’ 
 rp- 5’-GATCTCATGGCTGTGACGTAG-3’ 
p2 fp- 5’-GGTGTGAAGATTTATGGTTGCC-3’ 
 rp- 5’-AGGTGTGGAACTAGAGGAGTAG-3’ 
p3 fp- 5’-GCATGTTCTCCTTGCGTTTG-3’ 
 rp- 5’-CATCCACACACACACTCATACA-3’ 
p4 fp- 5’-CAGACTTGCCATTGTAGCCTAT-3’ 
 rp- 5’-GGCGAGCCCTGATGAATAAA-3’ 
p5 fp- 5’-AGGATCAAGTGAGCGAGTTTAG-3’ 
 rp- 5’-TCAGAGGGAAGAAAGTGGAAAG-3’ 
p6 fp- 5’-GATGGCTTTCTCCCGCTTAT-3’ 
 rp- 5’-CTATCTGTGGAACCTAGCATGAC-3’ 
p7 fp- 5’-TATCCGAGACCAGGTGTAGTT-3’ 
 rp- 5’-GCACCTGCTGAGGATGTTAT-3’ 
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4.1 Conclusions 
         It has been a long-standing question in the cohesinopathy field as to what is the 
underlying molecular mechanism of RBS/CdLS phenotypes, in part due to the diverse 
roles of cohesin and its auxiliary factors in various cis and trans-DNA tethering events 
such as cell division, chromatin organization and transcriptional processes (Ball et al., 
2014; Barbero, 2014; Gerton, 2012; Horsfield et al., 2012; Mehta et al., 2013; Skibbens., 
2013; Dorsett, 2016; Cucco and Musio, 2015; Zakari et al., 2015; Bose et al., 2012; Liu 
and Krantz, 2008; Rudra and Skibbens, 2013; Kawauch et al., 2016; Dorsett D, 
Merkenschlager et al., 2013; Dorsett and Krantz et al., 2009; Banerji et al, 2016; Banerji 
et al., 2017). The past few years have witnessed important advances made in this field, 
however, crucial questions regarding the etiology of RBS in particular still remained 
unanswered. My research exploits the zebrafish regenerating caudal fin to uncover a 
transcriptional basis for RBS. My findings provide strong evidence that ESCO2 plays a 
transcriptional role and suggests that the skeletal phenotypes of RBS arise through cis-
DNA tethering defects resulting in transcriptional deregulation of developmental 
programs (Banerji et al., 2016; Banerji et al, 2017 submitted).  
         In Chapter 2, I provide details of my findings that suggest that Esco2 knockdown 
results in transcriptional deregulation, independent of apoptosis, thus challenging the 
popular mitotic model of RBS. Using ISH and qRT-PCR techniques I show that Esco2 
regulates the expression of clinically relevant cx43 gene, linked to a similar skeletal 
disorder, ODDD. By using a transgenic Cx43 overexpression line, I demonstrate rescue 
of Esco2-dependent skeletal phenotypes. These results provide strong evidence that link 
Esco2 with Cx43 during bone growth and skeletal patterning (Banerji et al., 2016). These 
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findings open up crucial questions regarding the mechanism underlying the Esco2-Cx43 
skeletal pathway. One such question I became interested in was if Esco2 functions in a 
cohesin-dependent manner in regulating cx43 expression? In Chapter 3, I extend my 
previous findings by testing the role of the cohesin subunit, Smc3 (a known target of 
Esco2) in regulating the expression of cx43. I show that MO-mediated knockdown of 
Smc3 perturbs bone and tissue regeneration. The results are similar to those previously 
reported for Esco2 knockdown that includes defects in bone segment growth, tissue 
regeneration and cx43 expression (discussed in Chapter 2). Additionally, I provide 
evidence of rescue of Smc3-dependent bone and tissue regeneration defects using the 
transgenic cx43 overexpression line. These findings provide evidence that Smc3 directly 
contributes to RBS-type phenotypes in the regenerating fin model. Moreover, ChIP 
assays using zebrafish AB9 cells revealed that Smc3 binds to a discrete region of the 
cx43 promoter, suggesting that Esco2 exerts transcriptional regulation of cx43 through 
modification of Smc3 bound to the cx43 promoter (Banerji et al., 2017, in revision, 
Biology Open). Combined findings from Chapter 2 and 3, combined with the established 
role for Esco2 in Smc3-acetylation, I provide compelling support for a model where 
Esco2 and Smc3 act on the promoters of skeletal genes (i.e. cx43) to regulate 
transcription and thereby mediate phenotypes of RBS (Figure 3.8).  
         Overall, the work compiled in this dissertation highlights the following important 
revelations regarding the etiology of RBS. First, Esco2 knockdown in regenerating fin is 
established as a powerful system for elucidating the molecular basis of RBS. Second, a 
novel role of esco2 in regulating the transcription of a clinically important gene, cx43 is 
uncovered. Third, I show that cohesin subunit, Smc3 functions in a similar manner as 
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Esco2 in regulating the expression of cx43 gene. Fourth, I provide mechanistic insights 
into how Esco2 regulates cx43 expression i.e. Smc3 binds to a discrete region of the cx43 
promoter. These findings suggest a unified transcriptional mechanism that underlies both 
RBS and CdLS. 
 
Proposed unified model of Cohesinopathy diseases 
          Considering the findings from my research work, along with evidence from other 
groups, I challenge the notion that CdLS and RBS represent separate syndromes (Banerji 
et al., 2016; Choi et al., 2010; Kim et al., 2008; Morita et al., 2012; Kaur et al., 2005; 
Ghiselli et al., 2006; Fazio et al., 2016; Pistochhi et al., 2013; Schuster et al., 2015; Leem 
et al., 2011; Xu et al., 2016). My work provides tangible evidence for a unified 
mechanism underlying RBS and CdLS (discussed in the review article, Banerji et al., 
2017, in revision). It is important to take into consideration findings from various groups 
and reinterpret the underlying mechanisms of RBS/CdLS. Currently, there is enough 
evidence that mutations in esco2 not only impact apoptosis but also transcriptional 
regulation. Furthermore, along with transcriptional deregulation there is evidence that 
mutations in genes associated with CdLS also cause apoptosis through mitotic failure 
(Kaur et al., 2005; Ghiselli, 2006; Fazio et al., 2016; 306 Schuster et al., 2015; Pistocchi 
et al., 2013; Leem et al., 2011, Choi et al., 2010, Banerji et al., 2016, Xu et al., 2016; 
Cucco and Musio, 2016). But why do cells from RBS and CdLS exhibit distinct 
morphology? Why are cohesion defects a prominent feature of RBS and not apparent in 
CdLS?  
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         I speculate that the lack of cohesion defects in CdLS is due to the heterozygosity 
involved in the disease. CdLS arise due to dominant mutations in genes coding for 
structural components of the cohesion ring (Krantz et al., 2004; Tonkin et al., 2004; 
Musio et al., 2006; Deardorff et al., 2007; Deardorff et al., 2012a; Deardorff et al., 2012b; 
Yuan et al., 2015; Liu and Krantz, 2009). In contrast, RBS is caused by recessive 
mutations in the gene coding for an enzymatic activity that regulates ring closure (Vega 
et al., 2005; Schule et al., 2005; Gordillo et al., 2008). Thus dosage of the cohesion 
pathway genes may play a vital role in this purpose. For instance, RBS cells and model 
systems exhibit significant loss of cohesion function resulting from trans-DNA tethering 
defects (Monnich et al., 2011; Morita et al., 2012; Percival et al., 2015; Whelan et al., 
2012; Van der Lejij et al., 2009). These mitotic failures, and the subsequent induction of 
apoptosis, potentially disguise underlying cis-DNA tethering defects. My PhD. thesis 
work suggests that a moderate loss of Esco2 function results primarily in cis-DNA 
tethering defects. Autosomal recessive transmission for RBS is consistent with requiring 
a greater decrease in ESCO2 to achieve transcriptional defects. At this reduced level of 
ESCO2 function, chromosome segregation defects also are prominent. On the other hand, 
autosomal dominant transmission requires only a modest loss of cohesion pathway 
activity, leading to defects in transcription. At this level of function, mitotic defects are 
not prominent. Therefore, I can propose that transcriptional deregulation is the 
predominant mechanism through which both RBS and CdLS arise, although the 
contributing role for mitotic failure and apoptosis cannot be ruled out (Figure 4.1). 
Further studies are required for support for the unified model of cohesinopathies. Below, 
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I summarize some of the future directions that would provide additional evidence for the 
transcriptional model of RBS. 
 
4.2 Future Direction 
(1) To determine if the Smc3 association with the cx43 promoter is dependent on 
Esco2 acetylation 
         In Chapter 3, I provide evidence of Smc3 binding to the cx43 promoter region and 
provide support of a cohesin-mediated Esco2-dependent model of RBS (Figure 3.8). In 
this model, it is proposed that acetyltransferace activity of Esco2 is required for the 
activation its target, Smc3 that binds the cx43 promoter, thus regulating cx43 
transcription. This model is based on the consideration that Esco2 functions as its 
established role of an acetlytransferase (Bellows et al., 2003; Skibbens et al., 1999; Toth 
et al., 1999; Ivanov et al., 2002; Zhang et al., 2008; Unal et al., 2008; Ben-Shahar et al., 
2008; Hou and Zou, 2005). Thus it will be interesting to test the established role of Esco2 
in regulating cx43 expression. To functionally link Smc3 binding and gene regulation 
with Esco2 activity, it is important to test if Smc3 binds to the cx43 promoter in a Esco2-
dependent fashion. This could be achieved by performing Smc3-ChIP at the cx43 
promoter on Esco2 knockdown AB9 cells. If significant Smc3 binding is not observed at 
the p2 region of the cx43 promoter in Esco2 knockdown cell lysates, then that infers the 
Esco2 dependency in the proposed cohesin-mediated transcriptional model of RBS, 
supporting the hypothesis. The results for this experiment are extremely important to 
further strengthen the proposed model and provide evidence that Esco2 functions as an 
acetyltransferase and thus activating cohesins.  
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 (2) Promoter analysis of cx43 to determine the functional sequence required for 
Smc3 binding for regulating cx43 expression 
         Future studies should be aimed to quantify and detect measurable changes in 
transcription from the putative cx43 promoter. For achieving this goal reporter constructs 
for cx43 can be generated. The zebrafish cx43 promoter is approximately 6.7 kb in 
length, adjacent to an additional connexin gene (cx32.2) that resides upstream of the cx43 
coding sequence (Chatterjee et al., 2005). AB9 cells can be transfected with cx43-
luciferase reporters followed by detection of transcription. This experiment is important 
to answer two important questions. First, with this set up the functional impact of Esco2 
dependency can be tested. For example, the luciferase assay (Solberg and Krauss, 2013) 
can be performed on Esco2 knockdown AB9 cells followed by luciferase quantification 
that will determine the functional requirement of Esco2 on cx43 transcription. Second, in 
order to determine the functional promoter sequence requirement, cx43 reporter 
constructs with point mutations and deletions in the cx43 promoter can be generated 
followed by measurement of transcription. These experiments would provide additional 
evidence in support of the RBS transcriptional model (Figure 3.8). 
 
(3) To demonstrate chromosome looping as a mechanism of transcriptional 
regulation in RBS 
        Genome-wide studies show strong evidence of direct association of cohesin subunits 
and its auxiliary factors with developmental genes. One of the possible mechanisms 
underlying the transcriptional regulation of cohesin is via long distance DNA loops. The 
DNA loop formation during transcription is not new concept, as there are historical 
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evidence of such phenomenon in bacteria and bacteriophage systems (Ptashne, 1986; 
Hoover et al., 1990; Luijsterburg et al., 2008; Saiz and Vilar, 2006; Kagey et al., 2010). 
There are several evidences from various groups that show cohesin facilitates such 
looping mechanism (Hadjur et al., 2009, Mishiro et al., 2009; Nativio et al., 2009; Hou et 
al., 2010). Interestingly, in mouse embryonic stem cells cohesin binding initiates 
enhancer-promoter interaction via DNA loops in transcriptionally active genes (Kagey et 
al., 2010). This study provides in vivo evidence of physical interaction and co-occupancy 
of the cohesin, mediator and NIBPL at the enhancer and core promoter regions of 
particularly active genes (Figure 1.2). Keeping this mechanism as a common notion 
during transcriptional regulation, I propose a cohesion-mediated Esco2 dependent model 
of RBS (Figure 3.8), where activated Smc3 binds to the cx43 promoter region that 
facilitates conformational changes bringing the enhancer- cx43 promoter in close 
proximity. In Chapter 3, I provide evidence of Smc3 association with the cx43 promoter 
region, but it is important to test if the mechanism is via chromatin looping and also the 
involvement of enhancers in cx43 regulation. The spatial organization of chromatin can 
be tested by performing Chromosome conformation capture (3C) technique (Kagey et al., 
2010). 
 
(4) To determine if Esco2 regulates cx43 transcription via association of 
transcription factors  
        I provide support of a cohesin-dependent mechanism of cx43 regulation, which is 
one of the many ways that cx43 could be regulated by Esco2 (Chapter 3). There lies a 
possibility that the link between Esco2 and Cx43 is cohesin-independent (Figure 4.2). 
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Transcription factors can bind to Esco2 in regulating cx43 expression. One potential 
candidate is notch, since a similar role of Esco2 in regulating notch transcription has been 
previously reported (Leem et al., 2011). Notch signaling is evolutionary conserved in all 
vertebrates and is crucial for regulating various developmental programs. The 
transcription factor notch associates with Esco2 and is sequestered away from the 
promoter binding sites during the differentiation of neuronal cells. Another study reported 
reduction in notch1a expression in Esco2 depleted medaka mutants (esco2R80S) providing 
additional evidence of Esco2 and Notch association (Morita et al., 2012).  
         Another potential transcription factor that may also play an important role is CTCF. 
There are many evidence that link cohesin and CTCF and suggest their role in gene 
expression (Wendt and Peters, 2009; Wendt et al., 2008; Hadjur et al., 2009; Hou et al., 
2010; Kagey et al., 2010; Ball et al., 2014; Parelho et al., 2008; Rubio et al., 2008; 
Degner et al., 2011; Nativio et al., 2011; Majumder and Boss, 2011; Guo et al., 2012). In 
a 2008 study, 9000 cohesin sites were mapped in the entire non-repetitive part of the 
human genome, which showed 89% of these sites identical with CTCF sites (Wendt et al. 
2008). It will be interesting to see if these factors are dependent on Esco2 and if yes, then 
how is cx43 expression affected. This is important to understand the alternative 
mechanisms that may link Esco2 and Cx43 during skeletal growth and patterning. If this 
model is true, it will provide evidence that Esco2-binding factors may regulate cx43 
expression, which is separate from its well-established acetyltransferase role. The 
schematic of the proposed model is depicted in Figure 4.2. 
        Additionally there are few transcription factors that are reported to associate with 
cx43 but their dependency on Esco2 is yet to be tested. The list of genes that can be 
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included to test the model (Figure 4.2) are Nkx2.5, Runx2, Tbx2 and Tbx3, SOX4, and 
SOX2, β-catenin, and Msx1 (Chatterjee et al., 2005; Boogerd et al., 2011; Xia et al., 2010; 
Boogerd et al., 2008; Chen et al., 1995; Chatterjee et al., 2001). These factors could either 
induce or repress cx43 expression but their link with Esco2 needs to be tested.     
  
(5) To determine if Esco2 regulate cx43 transcription by the association of 
chromatin-remodeling complexes 
         It is now widely accepted that eukaryotic gene expression is regulated not only by 
basal transcriptional machinery but also by chromatin structural changes. Thus it is 
possible that Esco2 recruits chromatin-remodeling complexes to cx43 promoter for 
regulating its transcription. There are evidence that suggest association of Esco2 with the 
CoREST complex and also with other chromatin modifying enzymes (Kim et al., 2008). 
Other evidence show chromatin- remodeling complexes such as methyltransferases 
(SETDB1, G9a and suv39h1) and demethylases (LSD1) bind to Esco2 independent of 
acetyltransferase activity (Choi et al., 2010; Skibbens et al., 2013). Involvement of such 
factors will provide additional mechanisms through which Esco2-binding factors may 
regulate cx43 expression which is separate from it’s well established acetyltransferase 
role. The schematic of the proposed model is depicted in Figure 4.2. Similarly, it will be 
interesting to test the Esco2 dependency on this model and to determine how cx43 
expression is affected.  
 
 
 
	 140
(6) To determine novel binding partners of Esco2 in regulating cx43 expression 
        Currently, very few known partners of Esco2 have been identified. In order to 
understand the alternative mechanisms underlying Esco2-Cx43 regulation it will be 
valuable to adapt a priori approach for identifying novel binding partners of Esco2. Since 
my findings show that Esco2 knockdown results in reduction of cx43 expression, it is 
possible that there are novel partners that participate in direct binding of repressors away 
from the cx43 promoter. To address this strategy, mass spectrometric analysis can be 
performed to identify Esco2 associated factors. This should be followed by testing for 
candidate factor binding to cx43 promoter in the presence and absence of Esco2. 
Generation of a candidate list will be extremely helpful for testing the physical link 
between the candidates and Esco2. This strategy of producing a candidate list of Esco2-
dependent binding factors will open up new ways to identify possible mechanisms 
underlying Roberts Syndrome. 
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4.3 Figures 
 
 
 
 
 
 
Figure 4.1: Mechanisms of cohesinopathies. Transcriptional deregulation caused by 
defects in cis-DNA tethering events is the predominant mechanism through which both 
RBS and CdLS arise. The extent to which mitotic failure and apoptosis caused by defects 
in trans-DNA tethering events contribute to cohesinopathies requires further inquiry. 
 
Source: Review article, Banerji et al., 2017, (In press, Developmental Dynamics) 
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Figure 4.2: Cohesin-independent model of Esco2-Cx43 regulation. Proposed model of 
Esco2 regulating cx43 transcription via transcription factors or chromatin remodeling 
complexes. Chromatin modifiers or transcription factors bind Esco2 may be recruited to 
the cx43 promoter for transcriptional regulation. 
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